,date,information,related
0,2022-08-23,"Headline: Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio, source:Yahoo, summary: Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.",DXCM
1,2022-09-23,"Headline: DexCom Inc. stock underperforms Friday when compared to competitors, source:MarketWatch, summary: Shares of DexCom Inc. slid 0.37% to $80.66 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index...",DXCM
2,2022-09-28,"Headline: Better Growth Stock: Intuitive Surgical vs. DexCom, source:Yahoo, summary: Growth stocks have received much of investors' ire throughout the current market downturn.  Intuitive Surgical is the leader in the robotic-assisted surgery (RAS) market, thanks to its crown jewel, the da Vinci surgical system.  The great thing about Intuitive Surgical's business is the growth potential that the RAS market boasts.",DXCM
3,2022-09-29,"Headline: Dexcom Schedules Third Quarter 2022 Earnings Release and Conference Call for October 27, 2022 at 4:30 p.m. Eastern Time., source:Yahoo, summary: SAN DIEGO, September 29, 2022--DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its third quarter 2022 financial results after market close on Thursday, October 27, 2022. Management will hold a conference call to review the company's third quarter 2022 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on the Dexcom investor relations website at investors.dexcom.com and w",DXCM
4,2022-09-30,"Headline: 3 Reasons to Hold DexCom (DXCM) Stock in Your Portfolio, source:Yahoo, summary: Investors continue to be optimistic about DexCom (DXCM) owing to its strong product portfolio.",DXCM
5,2022-10-02,"Headline: 2 Evergreen Growth Stocks to Buy and Hold Forever, source:Yahoo, summary: Commonly enough, evergreens have staying power because they're getting a steady boost from ultra long-term trends in the population or the economy, and that's part of the secret sauce that can make them killer investments.  With that in mind, let's analyze a pair of evergreen growth stocks that have already made quite a few investors richer by smashing the market's returns over the last 10 years.  Medical device company DexCom's (NASDAQ: DXCM) makes wearable continuous glucose monitors (CGMs) that help people with diabetes get minute-by-minute data about their blood glucose levels, thereby giving them better control of their symptoms.",DXCM
6,2022-10-03,"Headline: Tracking Philippe Laffont's Coatue Management Portfolio - Q2 2022 Update, source:SeekingAlpha, summary: Philippe Laffont's 13F portfolio value decreased from $13.67B to $8.26B this quarter. Read more about Coatue Management's holdings and trades for Q2 2022., Headline: Dexcom G7 Launches in the United Kingdom, Ireland, Germany, Austria and Hong Kong – Initiating Global Rollout of World's Most Powerful Continuous Glucose Monitoring System, source:Finnhub, summary: People with diabetes in the United Kingdom, Ireland, Germany, Austria and Hong Kong can get started with Dexcom G7 nowThe new CGM system is also expected to launch in New Zealand and South Africa... | October 4, 2022",DXCM
7,2022-10-04,"Headline: DexCom announces Dexcom G7 CGM availability in five new countries, source:Thefly.com, summary: DexCom announced the Dexc... DXCM, Headline: DexCom Launches G7 System in Key Markets Across Europe and Asia, source:TipRanks, summary: Medical devices provider DexCom (NASDAQ:DXCM) has launched its continuous glucose monitoring system DexCom G7 across the U.K., Ireland, Germany, Austria, and Hong K..., Headline: Dexcom G7 Launches in the United Kingdom, Ireland, Germany, Austria and Hong Kong – Initiating Global Rollout of World’s Most Powerful Continuous Glucose Monitoring System, source:Yahoo, summary: SAN DIEGO & EDINBURGH, Scotland, October 04, 2022--DEXCOM G7 LAUNCHES IN THE UNITED KINGDOM, IRELAND, GERMANY, AUSTRIA AND HONG KONG – INITIATING GLOBAL ROLLOUT OF WORLD’S MOST POWERFUL CGM SYSTEM, Headline: Why DexCom Was Such a Healthy Stock Today, source:Yahoo, summary: There's nothing like a strategic product rollout to push the price of a stock higher.  This was the case with medical device maker DexCom (NASDAQ: DXCM), which on news of international expansion saw its share price zoom more than 7% higher on Tuesday.  DexCom, which specializes in continuous glucose monitoring (CGM) solutions for diabetics, announced earlier in the day that it is expanding into new markets.",DXCM
8,2022-10-05,"Headline: Citi ups DexCom target, opens 'positive catalyst watch', source:Thefly.com, summary: Citi analyst Joanne Wuens... DXCM, Headline: Bull of the Day: DexCom, Inc. (DXCM), source:TalkMarkets, summary: DexCom makes continuous glucose monitoring systems designed for people with diabetes., Headline: Nasdaq Bear Market: 2 Top Stocks You Can Buy With $200 Right Now, source:Yahoo, summary: The Nasdaq Composite has tumbled a frightening 31% since the beginning of 2022, and nobody knows when the carnage will end.  It's hyper-popular because physicians can use Doximity Dialer on their personal devices without sharing any personal contact information., Headline: 2 Beaten-Down Stocks That Could Be Great Long-Term Buys, source:Yahoo, summary: Investing in equities during a downturn can be challenging.  With that in mind, let's examine two stocks that have lagged the market this year but could be significant winners in the long run: HCA Healthcare (NYSE: HCA) and DexCom (NASDAQ: DXCM).  Here's the thing about healthcare stocks -- medical services are always in demand., Headline: DexCom and Papa John's International have been highlighted as Zacks Bull and Bear of the Day, source:Yahoo, summary: DexCom and Papa John's International are part of the Zacks Bull and Bear of the Day article.",DXCM
9,2022-10-06,"Headline: What You Missed On Wall Street On Friday, source:Thefly.com, summary: Five top five lists with the news and calls moving stocks, powered by The Fly. DKNG, DIS, META, FDX, AMT, VOD, NVDA, AMD, CVS, CANO, BAC, LEVI, LYFT, ZM, UBER, GS, NSC, U, PAYO, DXCM, CS, LAC, ALLO, ACCD, AEHR, TLRY, LPRO, NRIX, Headline: Piper says DexCom will get highest multiple in diabetes after CMS update, source:Thefly.com, summary: Piper Sandler analyst Mat... DXCM, ABT",DXCM
10,2022-10-07,"Headline: DexCom price target raised to $120 from $112 at Stifel, source:Thefly.com, summary: Stifel analyst Mathew Bla... DXCM, ABT, Headline: Early notable gainers among liquid option names on October 7th, source:Thefly.com, summary: Notable gainers among liq... DXCM, ABT, COP, APA, EOG, Headline: DexCom Up After Medicare Proposal Looking at Covering CGMs, source:TipRanks, summary: Shares of DexCom (NASDAQ: DXCM) were up in morning trading on Friday after the Centers for Medicare and Medicaid Services (SMC) issued a proposal to determine local..., Headline: What You Missed On Wall Street This Morning, source:Thefly.com, summary: Five top five lists with the news and calls moving stocks, powered by The Fly. DKNG, DIS, JNJ, BIIB, AMD, CVS, CANO, BAC, AMBC, LEVI, LYFT, UBER, ZM, GS, NSC, U, META, AAPL, GOOG, GOOGL, PAYO, DXCM, CS, LAC, ALLO, ACCD, AEHR, TLRY, LPRO, NRIX, Headline: We're Changing Our DexCom Strategy as the Shares Move Higher, source:Yahoo, summary: On July 15 we reviewed the charts of medical device maker DexCom and wrote that ""Aggressive traders could probe the long side of DXCM around current levels. Risk to $72. Maybe we can rally to the $100 area., Headline: Dexcom (DXCM) Gets a Buy from Stifel Nicolaus, source:TipRanks, summary: In a report released today, Mathew Blackman from Stifel Nicolaus maintained a Buy rating on Dexcom (DXCM &#8211; Research Report), with a price target of $120.00. T..., Headline: Stocks making the biggest moves midday: CVS, Credit Suisse, AMD, Lyft and more, source:CNBC, summary: These are the stocks posting the largest moves in midday trading. , Headline: 11 Best Fitness Stocks To Invest In, source:Yahoo, summary: In this article, we discuss 11 best fitness stocks to invest in. If you want to read about some more fitness stocks, go directly to 5 Best Fitness Stocks To Invest In. Online training continues to gain traction in the fitness world even as the restrictions of the coronavirus are being relaxed in almost all […], Headline: DexCom Shares Up 9.4% After CMS Proposal That Could Benefit Its Products, source:MarketWatch, summary: By Kathryn Hardison Shares of DexCom Inc. rose 9.4% to $104.20 on Friday after the Centers for Medicare and Medicaid Services issued a local coverage..., Headline: Dexcom stock pops as Medicare considers coverage for diabetic monitors, source:Yahoo, summary: Shares of Dexcom are up after Medicare proposed a local coverage determination for its diabetic monitors., Headline: Why DexCom Stock Popped on Friday, Even as the Market Crumbled, source:Yahoo, summary: The medical device maker could benefit from a pending decision by Medicare that could be a game changer.",DXCM
11,2022-10-08,"Headline: Wall Street Breakfast: What Moved Markets, source:SeekingAlpha, summary: Listen on the go! A daily podcast of Wall Street Breakfast will be available this morning on Seeking Alpha, iTunes, Stitcher and Spotify.",DXCM
12,2022-10-09,"Headline: 3 Diabetes Care Stocks That Could Help Set You Up for Life, source:Yahoo, summary: Diabetes has been on the rise for a while because of both the aging of the U.S. population -- as well as expanding waistlines.  According to the National Diabetes Statistics Report, 37.3 million people in the United States have diabetes, and 96 million in the U.S. have pre-diabetes, including 48.8% of the population that is 65 or older.  A recent report by Global Market Insights puts the compound annual growth rate for the diabetes care devices market at 10% between now and 2030, becoming an $88 billion market by that time.",DXCM
13,2022-10-10,"Headline: DexCom price target raised to $110 from $92 at BTIG, source:Thefly.com, summary: BTIG analyst Marie Thibau... DXCM, ABT, Headline: DexCom (DXCM) Soars 7.3%: Is Further Upside Left in the Stock?, source:Yahoo, summary: DexCom (DXCM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road., Headline: Company News for Oct 10, 2022, source:Yahoo, summary: Companies In The News Are: LEVI, AMD, DXCM, CANO, CVS., Headline: DexCom, Inc.'s (NASDAQ:DXCM) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?, source:Yahoo, summary: DexCom's (NASDAQ:DXCM) stock is up by a considerable 30% over the past three months. We wonder if and what role the...",DXCM
14,2022-10-11,"Headline: 2 Top Stocks to Buy in October and Hold Forever, source:Yahoo, summary: While the stock market may be facing a turbulent environment at the moment, it's always a good time to invest in wonderful companies with great businesses that can generate prolonged portfolio returns.  Now, with patent exclusivity on the drug set to expire in the U.S. in 2023, you'll be glad to learn that Abbvie also has other highly lucrative products on which to rely for future revenue and profits.  Taking a step back and looking at the healthcare stock's financial performance over the much longer period of five years, the company has boosted its annual revenue, net income, and cash from operations by 100%, 117%, and 129%, respectively., Headline: CMS proposal a positive for Med Tech sector, says Piper Sandler, source:Thefly.com, summary: Piper Sandler analyst Mat... ABMD, ATEC, APYX, ATRC, AZYO, BSX, CNMD, CUTR, RCEL, CVRX, DXCM, GKOS, GMED, HUMA, PODD, IART, MDT, UTRS, MIRO, MOTS, NUVA, KIDS, FNA, SPNE, SGHT, SYK, TNDM, TELA, TFX, ZBH",DXCM
15,2022-10-12,"Headline: DexCom initiated with a Buy at Jefferies, source:Thefly.com, summary: Jefferies analyst Matthew... DXCM, Headline: Expect Sideways Action From DexCom in the Short Run, source:Yahoo, summary: Here on Wednesday a sell side firm rated the medical device maker a new buy with a $125 price target, so let's check out DexCom's charts again.  In this daily bar chart of DXCM, below, we can see that prices gapped higher above the declining 200-day moving average line.  Prices have pulled back slightly from their upside surge., Headline: DexCom Inc. stock falls Wednesday, underperforms market, source:MarketWatch, summary: Shares of DexCom Inc. slid 1.36% to $98.32 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index...",DXCM
16,2022-10-13,"Headline: Here's How Much You'd Have If You Invested $1000 in DexCom a Decade Ago, source:Yahoo, summary: Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more., Headline: 12 Best IoT Stocks to Buy Now, source:Yahoo, summary: In this article, we discuss the 12 best Internet-of-Things (IoT) stocks to buy now. If you want to read about some more IoT stocks, go directly to 5 Best IoT Stocks to Buy Now. The Internet-of-Things (IoT) industry has advanced by leaps and bounds in the past few years, emerging from niche corners of the […], Headline: DexCom Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: Shares of DexCom Inc. advanced 3.46% to $101.72 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...",DXCM
17,2022-10-14,"Headline: Abbott has a new glucose monitor for diabetics — It's so small I forgot I was wearing it, source:CNBC, summary: CNBC's Erin Black, a type 1 diabetic, reviews Abbott's newest continuous glucose monitor, the Freestyle Libre 3., Headline: Abbott's Freestyle Libre 3 can discreetly monitor your blood sugar 24/7, source:CNBC, summary: Abbott Laboratories newest continuous glucose monitor is now available at participating retail pharmacies and through durable medical equipment suppliers. The Freestyle Libre 3 was approved by the FDA in June and is a step up from previous Abbott systems. CNBC's Erin Black, a type 1 diabetic, tested out the Libre 3 for over a month. Here is her review., Headline: DexCom Inc. stock falls Friday, underperforms market, source:MarketWatch, summary: Shares of DexCom Inc. slipped 4.24% to $97.41 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index...",DXCM
18,2022-10-17,"Headline: DexCom Inc. stock rises Monday, still underperforms market, source:MarketWatch, summary: Shares of DexCom Inc. rallied 2.38% to $99.73 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...",DXCM
19,2022-10-18,"Headline: DexCom Inc. stock underperforms Tuesday when compared to competitors, source:MarketWatch, summary: Shares of DexCom Inc. slid 2.81% to $96.93 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index...",DXCM
20,2022-10-19,"Headline: Ready to Buy the Dip? This Healthcare Stock Is a Smart Buy, source:Yahoo, summary: This bear market may not exactly put you in the mood for investing. But now is actually a great time to scoop up shares of solid companies. Why? Because many are trading at a discount. Yet their long-term outlooks remain bright., Headline: DexCom Inc. stock outperforms market despite losses on the day, source:MarketWatch, summary: Shares of DexCom Inc. shed 0.09% to $96.84 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...",DXCM
21,2022-10-20,"Headline: DexCom (DXCM) Earnings Expected to Grow: What to Know Ahead of Next Week's Release, source:Yahoo, summary: DexCom (DXCM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations., Headline: DexCom Inc. stock falls Thursday, underperforms market, source:MarketWatch, summary: Shares of DexCom Inc. shed 2.56% to $94.36 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index..., Headline: Baxter (BAX) to Report Q3 Earnings: Is a Beat in the Cards?, source:Yahoo, summary: Baxter's (BAX) third-quarter results are likely to reflect growth in its Medication Delivery and Advanced Surgery businesses. Hillrom's products are likely to have boosted sales., Headline: Is a Beat Likely for DexCom (DXCM) This Earnings Season?, source:Yahoo, summary: DexCom's (DXCM) third-quarter results are likely to reflect rising global awareness of its real-time CGM.",DXCM
22,2022-10-21,"Headline: Got $1,000? 3 Growth Stocks to Buy That Could Double Your Money, source:Yahoo, summary: If you're investing in the stock market right now, you know how challenging an environment it's been for investors of all trading styles lately.  If you have $1,000 to invest in the stock market right now, here are three great companies you may want to consider for your buy list.  DexCom (NASDAQ: DXCM) may not be a household name, but the products and services the company provides are not only constantly in demand but in many cases are lifesaving for its customers., Headline: DexCom Inc. stock rises Friday, still underperforms market, source:MarketWatch, summary: Shares of DexCom Inc. rallied 1.40% to $95.68 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...",DXCM
23,2022-10-23,"Headline: Baxter International: Despite Weakening On The Bottom Line, Shares Look Attractive, source:SeekingAlpha, summary: Baxter International has had a rough year or so, with shares declining far more than the market has. See why I'm changing my rating on BAX from Hold to a Buy.",DXCM
24,2022-10-24,"Headline: Video: S&P 500 Analyst Moves: DXCM, source:Market News Video, summary: The latest tally of analyst opinions from the major brokerage houses shows that among the components of the S&P 500 index, DexCom (DXCM) is now the #45 analyst pick, moving up by 1 spot - This rank is formed by averaging the analyst opinions for each component from each broker, and then ranking the 500 components by those average opinion values - DXCM., Headline: DexCom Moves Up In Analyst Rankings, Passing Horton, source:ETF Channel, summary: Staff article entitled DexCom Moves Up In Analyst Rankings, Passing Horton, about ETFs, from ETF Channel., Headline: Dexcom, Adam Schefter Announce Dexcom U, the First NIL Program for College Athletes With Diabetes, source:Yahoo, summary: SAN DIEGO, October 24, 2022--DEXCOM, ADAM SCHEFTER ANNOUNCE DEXCOM U, THE FIRST NIL PROGRAM FOR COLLEGE ATHLETES WITH DIABETES",DXCM
25,2022-10-25,"Headline: DexCom Inc. stock rises Tuesday, outperforms market, source:MarketWatch, summary: Shares of DexCom Inc. advanced 2.00% to $100.95 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...",DXCM
26,2022-10-26,"Headline: Should You Buy Dexcom (DXCM) Ahead of Earnings?, source:Yahoo, summary: Dexcom (DXCM) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season., Headline: Medical Device Stocks' Q3 Earnings on Oct 27: LH, BIO & More, source:Yahoo, summary: Medical Device players are likely to have benefited from the reopening of economies and several efforts to combat staffing challenges. Let's see how LH, BIO, BAX, DXCM and WST are likely to fare this time., Headline: DexCom Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: Shares of DexCom Inc. rallied 1.64% to $102.61 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones..., Headline: Teleflex price target lowered to $245 from $265 at Piper Sandler, source:Thefly.com, summary: Piper Sandler analyst Mat... TFX, BSX, DXCM, Headline: DexCom reports Q3 adjusted EPS 28c, consensus 24c, source:Thefly.com, summary: Reports Q3 revenue $769.6... DXCM, Headline: DexCom narrows FY22 revenue view to $2.88B-$2.91B from $2.86B-$2.91B, source:Thefly.com, summary: Consensus $2.89B.... DXCM",DXCM
27,2022-10-27,"Headline: Top 5 3rd Quarter Trades of Ri - GuruFocus.com, source:GuruFocus, summary: GuruFocus Article or News written by insider and the topic is about: , Headline: Dexcom (DXCM) Receives a Buy from BTIG, source:TipRanks, summary: BTIG analyst Marie Thibault maintained a Buy rating on Dexcom (DXCM &#8211; Research Report) yesterday and set a price target of $126.00. The company&#8217;s shares..., Headline: Notable companies reporting after market close, source:Thefly.com, summary: Notable companies reporti... AAPL, AMZN, TMUS, INTC, GILD, VRTX, EW, DXCM, COF, PINS, ZEN, FSLR, TXRH, Headline: DexCom Inc. stock underperforms Thursday when compared to competitors, source:MarketWatch, summary: Shares of DexCom Inc. slid 1.33% to $101.25 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones..., Headline: DexCom: Q3 Earnings Snapshot, source:Associated Press, The, summary: No summary, Headline: DexCom Shares Jump 9.6% on Adjusted 2022 Outlook, 3Q Rev Above Estimates, source:MarketWatch, summary: By Denny Jacob DexCom Inc. shares jumped 9.6% to $111 in after-hours trading Thursday after the company adjusted its 2022 revenue range guidance. The medical..., Headline: DexCom, Inc. (DXCM) Q3 2022 Earnings Call Transcript, source:SeekingAlpha, summary: DexCom, Inc. (NASDAQ:NASDAQ:DXCM) Q3 2022 Earnings Conference Call October 27, 2022, 04:30 PM ET Company Participants Sean Christensen - IR Kevin Sayer - Chairman, President and CEO Jereme..., Headline: Dexcom Reports Third Quarter 2022 Financial Results, source:Yahoo, summary: SAN DIEGO, October 27, 2022--Dexcom Reports Third Quarter 2022 Financial Results, Headline: DexCom (DXCM) Q3 Earnings and Revenues Surpass Estimates, source:Yahoo, summary: DexCom (DXCM) delivered earnings and revenue surprises of 16.67% and 2.25%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?, Headline: DexCom (DXCM) Q3 2022 Earnings Call Transcript, source:Yahoo, summary: Please note that there are also slides available related to our third quarter performance on the Dexcom Investor Relations website on the Events and Presentations page.  All forward-looking statements included in this presentation are made as of the date hereof based on information currently available to Dexcom and are subject to various risks and uncertainties.  The factors that could cause actual results to differ materially from those expressed or implied by any of these forward-looking statements are detailed in Dexcom's annual report on Form 10-K, most recent quarterly report on Form 10-Q, and other filings with the Securities and Exchange Commission.",DXCM
28,2022-10-28,"Headline: Dow Jones Futures: Apple Holds, Amazon Joins Megacap Meltdown; What To Do Now, source:Yahoo, summary: Apple dipped after the iPhone giant topped views. Amazon crashed on guidance, joining the megacap earnings meltdown., Headline: DexCom price target raised to $120 from $97 at Baird, source:Thefly.com, summary: Baird analyst Jeff Johnso... DXCM, Headline: DexCom price target raised to $117 from $105 at Citi, source:Thefly.com, summary: Citi analyst Joanne Wuens... DXCM, Headline: Healthcare Stocks Pace S&P 500 After Earnings, source:Yahoo, summary: The S 500 is moving higher Friday, and healthcare stocks are leading the way. The index’s largest gainer is DexCom, whose stock is up 17% on Friday afternoon. The company, which manufactures medical devices that help manage diabetes, reported third-quarter sales of $769 million and adjusted earnings of 28 cents a share on Thursday afternoon. Both figures easily topped the expectations of Wall Street analysts. Gilead Sciences shares are up 12%, good for second place in the index. The biotech repo, Headline: Premarket Movers: DaVita, Edwards Lifesciences, Pilgrim's Pride, source:MarketWatch, summary: With U.S. stock markets set to open in two hours, (PPC) was up 11.3% in pre-market trading, and (PINS) was up 10.1%. (CUBE), (DXCM), and (INTC) were all..., Headline: Early notable gainers among liquid option names on October 28th, source:Thefly.com, summary: Notable gainers among liq... DXCM, INTC, VRSN, GILD, TMUS, Headline: Analysts Have Conflicting Sentiments on These Healthcare Companies: Dexcom (DXCM), Gilead Sciences (GILD) and Laboratory (LH), source:TipRanks, summary: Companies in the  Healthcare sector have received a lot of coverage today as analysts  weigh in on Dexcom (<span class='tr-stock-ticker' style='color:blue; font-wei..., Headline: Stocks making the biggest moves midday: Apple, Amazon, Intel and more, source:CNBC, summary: These are the stocks posting the largest moves in midday trading. , Headline: Why DexCom Stock Is Soaring Today, source:Yahoo, summary: What happened Shares of DexCom (NASDAQ: DXCM) were trading up by 13.9% as of 11:55 a.m. ET Friday. The big gain came after the diabetes-care technology company announced its third-quarter results following the market close on Thursday., Headline: DexCom Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: Shares of DexCom Inc. surged 19.38% to $120.87 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500..., Headline: A Fresh Look at Medical Device Maker DexCom After Earnings, source:Yahoo, summary: Shares of DexCom gapped higher Friday after the company reported better-than-anticipated quarterly numbers Thursday evening. In our October 12 review of DXCM we wrote that ""The price of DXCM could pull back a little bit further in the short run., Headline: DexCom (DXCM) Q3 Earnings Beat Estimates, Guidance Revised, source:Yahoo, summary: DexCom's (DXCM) third-quarter results reflect strong domestic and international revenue growth on the back of its real-time Continuous Glucose Monitoring system., Headline: Dexcom Stock Soars on Earnings and Revenue Beat, source:Yahoo, summary: Dexcom  stock jumped after the medical device company beat earnings and revenue expectations for the third quarter, and tweaked its fiscal-year revenue guidance.  Dexcom (ticker: DXCM) reported third-quarter revenue of $769.6 million, an 18% increase from a year earlier, and adjusted earnings per share of 28 cents, up from 22 cents last year.  Dexcom, which makes continuous glucose monitoring systems, also updated its fiscal-year revenue guidance range to $2.88 billion to $2.91 billion., Headline: Top 10 Gainers on Friday, source:Yahoo, summary: In this article, we will take a look at the top 10 gainers on Friday. If you want to see some more stocks rallying today, go directly to Top 5 Gainers on Friday. All three key U.S. indices jumped this morning, thanks to better-than-expected earnings of giants like Apple Inc. (NASDAQ:AAPL), Intel Corporation (NASDAQ:INTC) and […], Headline: ClearBridge Large Cap Growth Strategy Q3 2022 Portfolio Manager Commentary, source:SeekingAlpha, summary: The ClearBridge Large Cap Growth Strategy underperformed the benchmark for Q3 2022. Click here to read the full fund letter.",DXCM
29,2022-10-30,"Headline: Under-the-radar trend shows tech investors remain loyal despite major losses this year, source:CNBC, summary: The widely held ARK Innovation ETF and the Technology Select Sector SPDR Fund aren't showing meaningful outflows so far this year., Headline: DexCom Stock: Bull vs. Bear, source:Yahoo, summary: DexCom's share price is still down more than 20% year to date.  Others think the maker of continuous glucose monitoring (CGM) systems is a much riskier proposition.  Here are the bull and bear cases for DexCom stock.",DXCM
30,2022-10-31,"Headline: Tracking Baillie Gifford's 13F Portfolio - Q3 2022 Update, source:SeekingAlpha, summary: Baillie Giffordâs 13F portfolio value decreased from ~$97.51B to ~$96.99B this quarter. Click here to find out the Q3 2022 portfolio update., Headline: Dexcom (DXCM) Receives a Buy from J.P. Morgan, source:TipRanks, summary: In a report released on October 28, Robbie Marcus from J.P. Morgan maintained a Buy rating on Dexcom (DXCM &#8211; Research Report), with a price target of $135.00...., Headline: Glucose monitoring device maker DexCom stock rallies more than 50% in October to pace the S&P 500, source:MarketWatch, summary: keep them on track to be the S&P 500's undefined best October performer with a month-to-date gain of 50.6%. The rally comes as maker of glucose monitoring..., Headline: DexCom Inc. stock outperforms market despite losses on the day, source:MarketWatch, summary: Shares of DexCom Inc. sank 0.07% to $120.78 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index...",DXCM
31,2022-11-01,"Headline: 7 Stocks Billionaires are Buying Now, source:Yahoo, summary: It isn’t easy to figure out which stocks billionaires are buying right now. With sky-high inflation, fears of recession, weak economic growth, Russia’s invasion of Ukraine, and a weaker consumer, the Dow Jones Industrial Average is down 12% on the year. The S&P 500 is down 21%, with the NASDAQ down about 32%. It’s been a terrible year. Yet, even as markets plunged, billionaire heavyweights have been buying beaten-down names.InvestorPlace - Stock Market News, Stock Advice & Trading Tips That’s be, Headline: Dexcom Partners With Warriors and Nonprofits to Artfully Advocate for Access to Diabetes Care, source:Yahoo, summary: SAN DIEGO, November 01, 2022--Dexcom partners with Warriors and nonprofits to artfully advocate for access to diabetes care, Headline: DexCom Inc. stock falls Tuesday, underperforms market, source:MarketWatch, summary: Shares of DexCom Inc. slid 1.44% to $119.04 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...",DXCM
32,2022-11-02,"Headline: Is DexCom a Good Healthcare Stock to Buy Now?, source:Yahoo, summary: After rising about 50% in October, investors want to know if this stock still has any fuel in the tank., Headline: DexCom Inc. stock falls Wednesday, underperforms market, source:MarketWatch, summary: Shares of DexCom Inc. slid 2.60% to $115.95 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index..., Headline: DexCom: After Q3, A Strong Competitive Advantage With Secular Tailwinds, source:SeekingAlpha, summary: DexCom had an excellent Q3, beating expectations and revising guidance. Market for diabetes remains large and growing, benefiting DexCom and its new G7 product. Read more here.",DXCM
33,2022-11-03,"Headline: DexCom Inc. stock falls Thursday, underperforms market, source:MarketWatch, summary: Shares of DexCom Inc. slipped 2.89% to $112.60 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500...",DXCM
34,2022-11-04,"Headline: Is It Too Late to Buy DexCom Stock?, source:Yahoo, summary: The shares have been surging after the medical device specialist released its latest earnings report., Headline: DexCom Inc. stock rises Friday, outperforms market, source:MarketWatch, summary: Shares of DexCom Inc. rallied 2.02% to $114.88 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...",DXCM
35,2022-11-05,"Headline: Vanguard Health Care Fund Exits Viatris, Plugs Into GSK in 3rd Quarter, source:GuruFocus, summary: No summary, Headline: Vanguard Health Care Fund Exit - GuruFocus.com, source:GuruFocus, summary: GuruFocus Article or News written by James Li and the topic is about: Health care-oriented fund releases quarterly portfolio, Headline: 2 Growth Stocks That Are Soaring: Are They Buys?, source:Yahoo, summary: Two such companies are DexCom (NASDAQ: DXCM) and Intuitive Surgical (NASDAQ: ISRG).  DexCom focuses on helping diabetes patients with its innovative continuous glucose monitoring (CGM) systems, which allow them to effortlessly keep track of their blood glucose levels throughout the day.  DexCom's key device is the G6, from which it currently makes most of its revenue.",DXCM
36,2022-11-07,"Headline: 2 Stock-Split Stocks That Are Crushing the Bear Market of Late, source:Yahoo, summary: These widely held stock-split stocks put the bear market in its place by respectively gaining 27% and 50% in October., Headline: 2 Reasons to Buy DexCom, and 1 Reason to Sell, source:Yahoo, summary: Now, investors want to know whether DexCom can continue riding that wave for a while -- and there are good reasons why it might.  DexCom develops continuous glucose monitoring (CGM) devices that help diabetes patients with an essential function: tracking their blood sugar levels.  CGM devices like DexCom's G6 compete with blood glucose meters (BGM) in helping people with diabetes with this critical task., Headline: DexCom Inc. stock rises Monday, still underperforms market, source:MarketWatch, summary: Shares of DexCom Inc. inched 0.39% higher to $115.33 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P...",DXCM
37,2022-11-08,"Headline: Got $1,000? 2 Bear Market Stocks to Jump On Right Now, source:Yahoo, summary: Regardless of what the market does next, these top stocks have a much longer growth trajectory ahead., Headline: Got $2,000? 2 Fantastic Stocks to Buy No Matter What the Market Does Next, source:Yahoo, summary: DexCom (NASDAQ: DXCM) is one of the preeminent forces in the continuous glucose monitoring (CGM) device industry, controlling a roughly 50% share of this multi-billion-dollar space.  The great advantage of DexCom's CGM devices is that users don't need finger sticks and can instead rely on a one-touch applicator paired with a small sensor and transmitter to keep track of their glucose levels.  The latest generation of DexCom's CGM device -- the G7, which has been approved in Europe, U.K, and Hong Kong, and is currently awaiting approval in the U.S. -- is 60% smaller than its G6 system and is ready to use in half an hour instead of two., Headline: DexCom Inc. stock rises Tuesday, still underperforms market, source:MarketWatch, summary: Shares of DexCom Inc. inched 0.02% higher to $115.35 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...",DXCM
38,2022-11-09,"Headline: DexCom (NASDAQ:DXCM) Is Doing The Right Things To Multiply Its Share Price, source:Yahoo, summary: What trends should we look for it we want to identify stocks that can multiply in value over the long term? Firstly..., Headline: DexCom Inc. stock falls Wednesday, still outperforms market, source:MarketWatch, summary: Shares of DexCom Inc. slid 1.91% to $113.15 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...",DXCM
39,2022-11-10,"Headline: 3 Reasons to Hold DexCom (DXCM) Stock in Your Portfolio, source:Yahoo, summary: Investors continue to be optimistic about DexCom (DXCM) owing to its strong product portfolio., Headline: DexCom Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: Shares of DexCom Inc. rose 5.91% to $119.84 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...",DXCM
40,2022-11-11,"Headline: How Dexcom's 'Biggest Ever' Launch Is Reinvigorating Its Stock, source:Yahoo, summary: Dexcom rallied higher on its third-quarter earnings and as it works to launch a new continuous glucose monitor in the U.S., Headline: 3 No-Brainer Growth Stocks to Buy for 2023 and Beyond, source:Yahoo, summary: When searching for growth stocks to buy, investors should first ascertain what growth means to them. It varies from person to person. I might define growth stocks as companies growing sales by 20% annually. You might feel the “true” growth stock is growing earnings by 15% annually. There’s no single definition that can be found in the Merriam-Webster dictionary. If I’m searching for three no-brainer growth stocks to buy for 2023 and beyond, my first criterion should be a company that pays no div, Headline: DexCom Inc. stock falls Friday, underperforms market, source:MarketWatch, summary: Shares of DexCom Inc. slid 3.24% to $115.96 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index...",DXCM
41,2022-11-14,"Headline: Dexcom Invites the Diabetes Community to #seediabetes This November and Share Their Diabetes Story With Custom Continuous Glucose Monitor (CGM) Patches, source:Yahoo, summary: EDINBURGH, Scotland, November 14, 2022--DexCom, Inc. (NASDAQ: DXCM), a global leader in real-time continuous glucose monitoring, its global partners and Dexcom Warriors will once again help the world #SeeDiabetes and empower members of the diabetes community to express their unique journey with diabetes in an accessible way – by creating custom Dexcom CGM patches via the newly launched design site that illustrate just how unique each person’s diabetes story is., Headline: DexCom Inc. stock falls Monday, underperforms market, source:MarketWatch, summary: Shares of DexCom Inc. shed 2.56% to $112.99 Monday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...",DXCM
42,2022-11-15,"Headline: DexCom Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: Shares of DexCom Inc. rallied 2.94% to $116.31 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...",DXCM
43,2022-11-16,"Headline: Top 5 3rd Quarter Trades of Alphabet Inc., source:GuruFocus, summary: No summary, Headline: 2 Unstoppable Growth Stocks to Buy in 2022 and Beyond, source:Yahoo, summary: While growth stocks aren't attracting the interest from investors that they were a few years ago, not all businesses that fall into this category of investments have dealt with the same headwinds as many former pandemic favorites.  Today, we're going to take a look at two top healthcare stocks with growth-driven businesses that have a robust track record of rewarding investors.  Intuitive Surgical (NASDAQ: ISRG) is a name known to many healthcare investors for its profitable and fast-growing surgical robotics business, which has led it to deliver a total return of about 345% to investors over the past decade., Headline: DexCom Inc. stock underperforms Wednesday when compared to competitors, source:MarketWatch, summary: Shares of DexCom Inc. slid 1.22% to $114.89 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...",DXCM
44,2022-11-17,"Headline: DexCom Inc. stock falls Thursday, underperforms market, source:MarketWatch, summary: Shares of DexCom Inc. slipped 1.96% to $112.64 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...",DXCM
45,2022-11-18,"Headline: Head-And-Shoulders Pattern Spots Short-Sale Entries, But Beware Of Potential Headaches, source:Yahoo, summary: When it comes to selling short, there is one pattern that stands head and shoulders above the rest, in a manner of speaking., Headline: DexCom Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: Shares of DexCom Inc. inched 0.96% higher to $113.72 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P..., Headline: 3 Stocks to Buy for Long-Term Growth Upside, source:Yahoo, summary: Investors might want to consider buying stocks after the strong first half of the fourth quarter. Today, we explore three stocks that are set to expand within three crucial growth industries.",DXCM
46,2022-11-21,"Headline: DexCom Inc. stock falls Monday, underperforms market, source:MarketWatch, summary: Shares of DexCom Inc. dropped 0.93% to $112.66 Monday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...",DXCM
47,2022-11-22,"Headline: Dexcom Announces Upcoming Conference Presentation, source:Yahoo, summary: SAN DIEGO, November 22, 2022--DexCom, Inc. (NASDAQ:DXCM) today announced that Matt Dolan, Executive Vice President, Strategy, Corporate Development and Dexcom Labs, will present an update on the company at the Piper Sandler 34th Annual Healthcare Conference on Wednesday, November 30, 2022 at 8:30am (EST)., Headline: DexCom Inc. stock falls Tuesday, underperforms market, source:MarketWatch, summary: Shares of DexCom Inc. slipped 1.46% to $111.01 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...",DXCM
48,2022-11-23,"Headline: DexCom Inc. stock rises Wednesday, outperforms market, source:MarketWatch, summary: Shares of DexCom Inc. advanced 1.72% to $112.92 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500..., Headline: Why The Market Rally Could Use A Holiday; Tesla Rebounds, 5 Stocks Near Buy Points, source:Yahoo, summary: The S&P 500 still faces its 200-day line with key economic data looming. Tesla rebounded from bear market lows while five medical stocks are near buy points.",DXCM
49,2022-11-24,"Headline: Dow Jones Futures Rise: 5 Stocks Near Buy Points In Market Rally; Tesla FSD Beta Expands Widely, source:Yahoo, summary: The S&P 500 still faces its 200-day line with key economic data looming. Tesla FSD Beta gets a wide release after TSLA stock jumped from bear market lows.",DXCM
50,2022-11-25,"Headline: Dexcom Leads 5 Stocks Near Buy Points, source:Yahoo, summary: Dexcom and other top stocks to watch this week combine strong technicals with generally solid fundamentals.",DXCM
51,2022-11-26,"Headline: Is This Stock-Split Stock a Buy For 2023?, source:Yahoo, summary: Over the past 10 months, several high-profile stock splits helped animate an already lively stock market.  One of them was that of the medical device expert DexCom (NASDAQ: DXCM), which completed a 4-for-1 stock split in June.  Of course, stock splits don't fundamentally change the prospects of the company, and DexCom's did little to jolt its stock performance in 2022.",DXCM
52,2022-11-28,"Headline: DexCom Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: Shares of DexCom Inc. inched 0.51% higher to $112.57 Monday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500...",DXCM
53,2022-11-29,"Headline: DexCom Inc. stock underperforms Tuesday when compared to competitors, source:MarketWatch, summary: Shares of DexCom Inc. shed 1.94% to $110.39 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...",DXCM
54,2022-11-30,"Headline: Truckers’ Health Adaptative Technology (T.H.A.T.) Study Evaluates the Impact of Digital Virtual Models of Care on the Health and Wellbeing of Professional Truck Drivers, source:Yahoo, summary: BURNABY, British Columbia, November 30, 2022--Dexcom, Inc. (NASDAQ: DXCM), - November is National Diabetes Awareness Month, time to bring attention to the prevalence and risk of diabetes within our diverse Canadian population, and to profile innovative strategies for prevention and management. In this context, Dexcom Canada is pleased to announce its participation in the Truckers’ Health Adaptive Technology (T.H.A.T.) project, as a digital heath technology partner, in support of improving health",DXCM
55,2022-12-01,"Headline: 3 Supercharged Growth Stocks to Buy for 2023, source:Yahoo, summary: If you're looking for stocks that can put up big gains next year, you've got more than a few viable options.  DexCom (NASDAQ: DXCM) is a niche medical device company that specializes in constant blood glucose monitors.  Keeping blood sugar in an ideal range doesn't just lead to better health outcomes; it can save healthcare plan sponsors a bundle., Headline: The Best Stocks to Invest $20,000 in Right Now, source:Yahoo, summary: DexCom (NASDAQ: DXCM) may not be a household name like some other healthcare stocks, but its products are a regular fixture of everyday life in millions of households globally.  Not only do these products generate robust demand by nature of the patients they serve, but DexCom wields control of roughly half of the entire CGM market worldwide.  Looking at the company's growth over the past three years, DexCom's annual revenue and net income have jumped by 66% and 53%, while the stock has generated an eye-popping total return of nearly 100%., Headline: 2 Monster Stocks to Buy Without Any Hesitation, source:Yahoo, summary: With that, let's take a look at two top growth stocks to consider adding to your portfolio before the year is out.  On the contrary, Etsy stands to benefit considerably from the consumer-driven tailwinds driving prolonged growth in the global e-commerce market, a space on track to hit a valuation of roughly $63 trillion by the year 2030., Headline: DexCom Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: Shares of DexCom Inc. advanced 1.50% to $118.03 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500...",DXCM
56,2022-12-02,"Headline: DexCom Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: Shares of DexCom Inc. inched 0.07% higher to $118.11 Friday, on what proved to be an all-around mixed trading session for the stock market, with the Dow..., Headline: Market Rally Resilient, But This Battle Continues; What To Do Now, source:Yahoo, summary: The market rally showed resilience with the S&P 500 holding its 200-day, but that fight isn't over. Chip giants Nvidia and TSM are in focus.",DXCM
57,2022-12-03,"Headline: Dow Jones Futures: Market Rally Resilient; What To Do Now, source:Yahoo, summary: The market rally showed resilience with the S&P 500 holding its 200-day, but that fight isn't over. Chip giants Nvidia and TSM are in focus.",DXCM
58,2022-12-04,"Headline: Dow Jones Futures Fall, Oil Prices Pop; 5 Stocks Near Buy Points In Resilient Market Rally, source:Yahoo, summary: The market rally showed resilience last week with the S&P 500 holding its 200-day. Crude prices rose as OPEC+ left output quotas steady.",DXCM
59,2022-12-05,"Headline: Tandem Diabetes Care: Undervalued Technology Leader, source:SeekingAlpha, summary: Tandem Diabetes Care has fallen over 70% YTD for several reasons. Click here to read why I rate TNDM stock a strong buy on turnaround potential in 2023., Headline: Dow Jones Futures Fall In Resilient Market Rally; Tesla Stock Falls On Production Cut, source:Yahoo, summary: Futures fell after the S&P 500 retook key levels last week. Oil prices rose. Tesla stock fell on China production cut reports., Headline: DexCom Inc. stock falls Monday, still outperforms market, source:MarketWatch, summary: Shares of DexCom Inc. slid 1.31% to $116.56 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index..., Headline: Dow Jones Leaders Caterpillar, Home Depot Headline These Best Stocks To Watch, source:Yahoo, summary: Dow Jones leaders Caterpillar and Home Depot are approaching new buy points, headlining today's best stocks to watch.",DXCM
60,2022-12-07,"Headline: DexCom Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: Shares of DexCom Inc. inched 0.92% higher to $117.91 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the Dow...",DXCM
61,2022-12-08,"Headline: FDA clears DexCom`s glucose monitoring system for all diabetes types aged 2 or older, source:Seeking Alpha, summary: No summary, Headline: BTIG Remains a Buy on Dexcom (DXCM), source:TipRanks, summary: No summary, Headline: Stocks making the biggest moves midday: GameStop, Dexcom, Cano Health and more, source:CNBC, summary: These are the stocks posting the largest moves in midday trading. , Headline: DexCom Shares Up 4% After FDA Approval of Continuous Glucose Monitoring System, source:MarketWatch, summary: By Kathryn Hardison Shares of DexCom Inc. increased 4.3% to $122.99 on Thursday following clearance from the Food and Drug Administration for its..., Headline: Dexcom G7 Receives FDA Clearance: The Most Accurate Continuous Glucose Monitoring System Cleared in the U.S., source:Yahoo, summary: SAN DIEGO, December 08, 2022--Dexcom G7 Receives FDA Clearance: The Most Accurate Continuous Glucose Monitoring System Cleared in the U.S., Headline: IBD Stock Of The Day Dexcom: How A Key FDA Decision Could Make It Actionable, source:Yahoo, summary: Dexcom stock jumped Thursday after the FDA cleared its next-generation continuous glucose monitor for patients with diabetes., Headline: DexCom Inc. stock rises Thursday, outperforms market, source:MarketWatch, summary: Shares of DexCom Inc. rose 4.04% to $122.67 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...",DXCM
62,2022-12-09,"Headline: Have $1,000? 2 Smart Stocks to Buy in a Nasdaq Bear Market, source:Yahoo, summary: With the Nasdaq Composite still firmly entrenched in bear market territory, if you're feeling discouraged about the state of your portfolio and the performance of some of your favorite stocks, you're certainly not alone.  Two stocks that in my view belong firmly in the former category are  DexCom (NASDAQ: DXCM) and Procter & Gamble (NYSE: PG).  If you're searching for a non-cyclical company with products that are consistently in demand, regardless of the macro environment or consumer sentiment, DexCom could be a no-brainer contender for your portfolio., Headline: DexCom Inc. stock underperforms Friday when compared to competitors, source:MarketWatch, summary: Shares of DexCom Inc. shed 5.06% to $116.46 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index...",DXCM
63,2022-12-12,"Headline: DexCom price target raised to $146 from $117 at Citi, source:Thefly.com, summary: No summary, Headline: Dexcom Canada Partners With Green Shield and The Health Depot to Offer Plan Members a Comprehensive Digital Diabetes Care Experience, source:Yahoo, summary: TORONTO, December 12, 2022--Dexcom, Inc. (NASDAQ: DXCM), a leader in real-time continuous glucose monitoring (rtCGM), announced today its partnership with Green Shield and The Health Depot digital pharmacy to provide Green Shield plan members with convenient access to the Dexcom G6 rtCGM System combined with virtual diabetes coaching support., Headline: DexCom Inc. stock rises Monday, still underperforms market, source:MarketWatch, summary: Shares of DexCom Inc. inched 0.27% higher to $116.78 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...",DXCM
64,2022-12-13,"Headline: DexCom Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: Shares of DexCom Inc. rose 2.38% to $119.56 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index...",DXCM
65,2022-12-14,"Headline: 3 Reasons to Hold DexCom (DXCM) Stock in Your Portfolio, source:Yahoo, summary: Investors continue to be optimistic about DexCom (DXCM) owing to its strong product portfolio., Headline: DexCom Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: Shares of DexCom Inc. rallied 1.61% to $121.49 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500...",DXCM
66,2022-12-15,"Headline: Piper Sandler medical tech analysts hold analyst/industry conference call, source:Thefly.com, summary: No summary, Headline: 2 Breakout Growth Stocks to Buy for the Long Haul, source:Yahoo, summary: Growth stocks aren't all the same, and it's fair to say that some may not recover from the period of volatility investors have witnessed over the past year.  DexCom (NASDAQ: DXCM) is an established leader in the diabetes care space, with a company history that spans more than three decades.  The stock's strong performance in such a volatile environment goes back to the consistent demand for its products, its non-cyclical business, and a series of successive wins of which investors have taken note., Headline: DexCom Inc. stock falls Thursday, underperforms market, source:MarketWatch, summary: Shares of DexCom Inc. shed 4.32% to $116.24 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...",DXCM
67,2022-12-16,"Headline: DexCom Inc. stock falls Friday, underperforms market, source:MarketWatch, summary: Shares of DexCom Inc. slid 1.39% to $114.63 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index..., Headline: DexCom (DXCM) Dips More Than Broader Markets: What You Should Know, source:Yahoo, summary: In the latest trading session, DexCom (DXCM) closed at $114.63, marking a -1.39% move from the previous day.",DXCM
68,2022-12-19,"Headline: 11 Best Medical Technology Stocks To Buy, source:Yahoo, summary: In this article, we discuss 11 best medical technology stocks to buy. If you want to see more stocks in this selection, check out 5 Best Medical Technology Stocks To Buy. The global medical devices market is expected to grow from $495.46 billion in 2022 to $718.92 billion by 2029 at a CAGR of 5.5% […], Headline: DexCom Inc. stock falls Monday, underperforms market, source:MarketWatch, summary: Shares of DexCom Inc. slid 2.09% to $112.23 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index...",DXCM
69,2022-12-20,"Headline: DexCom price target raised to $130 from $120 at Stifel, source:Thefly.com, summary: No summary, Headline: The Best Stocks to Invest $5,000 in Right Now, source:Yahoo, summary: If you have $5,000 to invest, here are two such stocks to consider adding to your portfolio ASAP.  Teladoc Health (NYSE: TDOC) came to the forefront of many investors' radars early in the pandemic when usage of telehealth services surged to an all-time high.  Looking at these pre-pandemic levels of growth, Teladoc's revenue growth of 86% in 2021 followed by 20% growth in the first nine months of 2022, while a deceleration, might be seen as a normalization to a more stable growth trajectory., Headline: DexCom Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: Shares of DexCom Inc. inched 0.82% higher to $113.15 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P...",DXCM
70,2022-12-21,"Headline: DexCom Inc. stock rises Wednesday, still underperforms market, source:MarketWatch, summary: Shares of DexCom Inc. rose 1.42% to $114.76 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...",DXCM
71,2022-12-22,"Headline: DexCom Inc. stock falls Thursday, still outperforms market, source:MarketWatch, summary: Shares of DexCom Inc. shed 0.94% to $113.68 Thursday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index..., Headline: DexCom (DXCM) Stock Moves -0.94%: What You Should Know, source:Yahoo, summary: DexCom (DXCM) closed the most recent trading day at $113.68, moving -0.94% from the previous trading session.",DXCM
72,2022-12-23,"Headline: DexCom Inc. stock underperforms Friday when compared to competitors, source:MarketWatch, summary: Shares of DexCom Inc. shed 1.97% to $111.44 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index...",DXCM
73,2022-12-27,"Headline: DexCom Inc. stock underperforms Tuesday when compared to competitors, source:MarketWatch, summary: Shares of DexCom Inc. slid 1.40% to $109.88 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...",DXCM
74,2022-12-28,"Headline: Early notable gainers among liquid option names on December 28th, source:Thefly.com, summary: No summary, Headline: 2 Growth Stocks to Invest $1,500 in Before the End of 2022, source:Yahoo, summary: If you're hunting for great companies to add to your portfolio before 2023 hits, here are two wonderful growth stocks that are no-brainer buys right now.  Healthcare has proven over the years to be a particularly resilient sector in a wide variety of market environments.  This is certainly true in the case of DexCom (NASDAQ: DXCM), a company that has delivered a total return nearly 700% for investors over past five years alone., Headline: DexCom Inc. stock outperforms competitors despite losses on the day, source:MarketWatch, summary: Shares of DexCom Inc. slumped 0.10% to $109.77 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500..., Headline: DexCom (DXCM) Stock Moves -0.1%: What You Should Know, source:Yahoo, summary: DexCom (DXCM) closed at $109.77 in the latest trading session, marking a -0.1% move from the prior day.",DXCM
75,2022-12-29,"Headline: Premarket Movers: Healthcare Realty Trust, DexCom, Tesla, source:MarketWatch, summary: With U.S. stock markets set to open in two hours, (DXCM) was up 5.9% in pre-market trading, and (TSLA) was up 4.4%. (PLNT), (IVZ), and (PLD) were all posting..., Headline: DexCom Inc. stock underperforms Thursday when compared to competitors despite daily gains, source:MarketWatch, summary: Shares of DexCom Inc. rose 2.10% to $112.07 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...",DXCM
76,2022-12-30,"Headline: Edwards Lifesciences: Catalysts For 2023 And Beyond, source:SeekingAlpha, summary: Edwards Lifesciences is down 40%+ this year. Read more to see EW's growth catalysts for 2023 and beyond and why I'll continue buying on any further dips., Headline: Diabetes rates in children set to skyrocket by 2060 - study, source:Seeking Alpha, summary: No summary, Headline: Have $2,000 to Invest? 2 Top Stocks That Could Go Parabolic, source:Yahoo, summary: Rather than jumping in and out of the market to try to capture the best or worst market moments, building your strategy on the basis of consistent investments in wonderful companies can help you generate and build upon portfolio returns through the years.  Despite being launched nearly two decades ago, Palantir (NYSE: PLTR) has remained a mystery to many until recently.  The company cut its teeth on lucrative contracts for highly secretive government agencies, and counts the Department of Defense, the Central Intelligence Agency, the National Security Agency, the Pentagon, the U.K. Ministry of Defense, and the Federal Bureau of Investigation among its clients., Headline: DexCom Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: Shares of DexCom Inc. rallied 1.04% to $113.24 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index..., Headline: DexCom (DXCM) Gains As Market Dips: What You Should Know, source:Yahoo, summary: In the latest trading session, DexCom (DXCM) closed at $113.24, marking a +1.04% move from the previous day.",DXCM
77,2023-01-03,"Headline: DexCom: Tremendous Growth Prospects, source:Seeking Alpha, summary: No summary, Headline: Dexcom to Present at 41st Annual J.P. Morgan Healthcare Conference, source:Yahoo, summary: SAN DIEGO, January 03, 2023--DexCom, Inc. (NASDAQ:DXCM) today announced that Kevin Sayer, Chairman, President and Chief Executive Officer, will present an update on the company at the 41st annual J.P. Morgan Healthcare Conference on January 9, 2023.",DXCM
78,2023-01-04,"Headline: DexCom Inc. stock underperforms Wednesday when compared to competitors, source:MarketWatch, summary: Shares of DexCom Inc. slipped 0.35% to $114.33 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500..., Headline: DexCom Inc. stock underperforms Thursday when compared to competitors, source:MarketWatch, summary: No summary",DXCM
79,2023-01-05,"Headline: 3 Reasons to Hold DexCom (DXCM) Stock in Your Portfolio, source:Yahoo, summary: Investors continue to be optimistic about DexCom (DXCM) owing to its strong product portfolio.",DXCM
80,2023-01-06,"Headline: 3 Reasons to Hold DexCom (DXCM) Stock in Your Portfolio (Revised), source:Yahoo, summary: Investors continue to be optimistic about DexCom (DXCM) owing to its strong product portfolio., Headline: Morgan Stanley Keeps Their Hold Rating on Dexcom (DXCM), source:TipRanks, summary: No summary, Headline: DexCom (NASDAQ:DXCM) shareholders have earned a 51% CAGR over the last five years, source:Yahoo, summary: We think all investors should try to buy and hold high quality multi-year winners. And highest quality companies can..., Headline: DexCom Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: Shares of DexCom Inc. advanced 3.70% to $115.82 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...",DXCM
81,2023-01-09,"Headline: Dexcom Reports Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2022 and Initial 2023 Outlook, source:Yahoo, summary: SAN DIEGO, January 09, 2023--DexCom, Inc. (Nasdaq: DXCM), the leader in real-time continuous glucose monitoring (""CGM""), today reported that it expects preliminary, unaudited revenue for the fourth quarter ended December 31, 2022 to be at least $815 million, an increase of 17% over the fourth quarter of 2021 on a reported basis and 20% on an organic1 basis. U.S. revenue is expected to be approximately $606 million, representing growth of 17% over the fourth quarter of 2021. International revenue, Headline: Dexcom Appoints Teri Lawver as Chief Commercial Officer, source:Yahoo, summary: SAN DIEGO, January 09, 2023--DEXCOM APPOINTS TERI LAWVER AS CHIEF COMMERCIAL OFFICER, Headline: 1 Top Growth Stock That Could Beat the Market In 2023 and Beyond, source:Yahoo, summary: Last year, the Nasdaq Composite experienced a downturn due to a combination of negative economic and political factors.  At any rate, economic issues won't last forever, and the market will eventually continue its march forward.  One growth stock that can help with that is none other than DexCom (NASDAQ: DXCM)., Headline: DexCom Inc. stock falls Monday, underperforms market, source:MarketWatch, summary: Shares of DexCom Inc. shed 4.97% to $110.06 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index...",DXCM
82,2023-01-10,"Headline: Want $1 Million in Retirement? Invest $300,000 in These 3 Stocks and Wait a Decade, source:Yahoo, summary: Turning an initial $300,000 investment into seven figures in a decade may seem like a lofty aspiration, but it would require an annualized return of just around 13% to make that happen.  Considering that the S&P 500 has delivered total returns of 220% over the past decade, which works out to 12.3% on an annualized basis, this begins to look like a much more attainable goal., Headline: DexCom Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: Shares of DexCom Inc. inched 0.75% higher to $110.88 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500..., Headline: DexCom (DXCM) Announces Solid Preliminary Q4 Revenues, source:Yahoo, summary: DexCom's (DXCM) revenue growth in the fourth quarter is likely to have been boosted by continued strength in its CGM sales.",DXCM
83,2023-01-11,"Headline: Covid-19 Still a Problem for Health Stocks, source:Yahoo, summary: A familiar foe has reappeared, and it could spell trouble for health stocks. Intuitive Surgical shares were down about 4% on Wednesday morning, the second-worst performer in the S 500. The company, which is a leader in robotic-assisted surgery, said it expects to book about $1.66 billion in fourth-quarter revenue, slightly below Wall Street expectations. The recent resurgence of Covid-19 in China helped explain the shortfall by disrupting non-essential surgeries, Intuitive said in a press releas, Headline: DexCom Inc. stock falls Wednesday, underperforms market, source:MarketWatch, summary: Shares of DexCom Inc. slipped 4.26% to $106.16 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500..., Headline: As Dexcom Settles, 2 Option Strategies Collect Premium, Minimize Risk, source:Yahoo, summary: Let's consider a combination of two strategies involving options with the goal being to collect as much premium upfront and minimizing our risk.",DXCM
84,2023-01-12,"Headline: DexCom Inc. stock rises Thursday, outperforms market, source:MarketWatch, summary: Shares of DexCom Inc. inched 0.92% higher to $107.14 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P..., Headline: DexCom (DXCM) Outpaces Stock Market Gains: What You Should Know, source:Yahoo, summary: DexCom (DXCM) closed at $107.14 in the latest trading session, marking a +0.92% move from the prior day.",DXCM
85,2023-01-13,"Headline: 2 Best Stocks to Buy in January and Hold Forever, source:Yahoo, summary: The start of a new year may or may not signal the recovery of the broader stock market, but great businesses are staying largely above the fray even if share prices remain volatile.  From healthcare to consumer goods, quality companies continuing to build upon a track record of growth that possess sticky business models and strong core financials can see share prices recover in the future.  Investors who continued to buy into these businesses at lower-than-usual valuations could be positioned well for this recovery when it does occur.",DXCM
86,2023-01-16,"Headline: Jerome Powell's Biggest Decision Of His Career Could Stop This Rally, What To Do, source:SeekingAlpha, summary: Fed has several remedies that can repress rising bullishness, all of them bitter pills to swallow for long only stockholders. Learn more about my suggestions.",DXCM
87,2023-01-17,"Headline: Dexcom G6 Real-Time CGM System Now Available to All Clients With Type 1 Diabetes Covered Under the Non-Insured Health Benefits Program, source:Yahoo, summary: BURNABY, British Columbia, January 17, 2023--Dexcom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (rtCGM), is pleased to announce that coverage for Dexcom G6 rtCGM System on the Non-Insured Health Benefits (NIHB) Program has been expanded to include all clients living with type 1 diabetes. This announcement expands upon coverage already in place for clients aged 2 to 19 on intensive insulin therapy, giving even more First Nations and Inuit people access to th, Headline: DexCom Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: Shares of DexCom Inc. inched 0.96% higher to $109.51 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500...",DXCM
88,2023-01-18,"Headline: DexCom Inc. stock falls Wednesday, underperforms market, source:MarketWatch, summary: Shares of DexCom Inc. slipped 2.63% to $106.63 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500...",DXCM
89,2023-01-19,"Headline: DexCom Inc. stock outperforms market despite losses on the day, source:MarketWatch, summary: Shares of DexCom Inc. slipped 0.40% to $106.20 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500...",DXCM
90,2023-01-20,"Headline: 2 No-Brainer Growth Stocks to Buy Right Now, source:Yahoo, summary: A discussion of ""growth stocks"" may not thrill investors quite the way it did just a year or two ago, but this type of investment is quite the horror show some make it out to be.  Here are two no-brainer growth stocks still worthy of the designation to consider adding to your portfolio before the end of January.  DexCom (NASDAQ: DXCM) has a relatively small portfolio of products, with its flagship product being its G series of continuous glucose monitoring (CGM) devices., Headline: DexCom (DXCM) Stock Benefited from Multiple Tailwinds in Q4, source:Yahoo, summary: Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” fourth quarter 2022 investor letter. A copy of the same can be downloaded here. In the fourth quarter, its Investor Class fund ARTMX returned -1.13%, Advisor Class fund APDMX posted a return of -1.12%, and Institutional Class fund APHMX returned -1.07%, compared to a […], Headline: DexCom (DXCM) Gains But Lags Market: What You Should Know, source:Yahoo, summary: DexCom (DXCM) closed the most recent trading day at $107.86, moving +1.56% from the previous trading session.",DXCM
91,2023-01-21,"Headline: What diabetes is revealing about the benefits and risks of personal medicine connected to the internet, source:CNBC, summary: Personal medical devices for conditions such as diabetes and sleep apnea are connecting to the internet, introducing privacy, hacking and health risks. , Headline: ClearBridge Large Cap Growth Strategy Q4 2022 Portfolio Manager Commentary, source:SeekingAlpha, summary: The ClearBridge Large Cap Growth Strategy outperformed its benchmark in the fourth quarter of 2022. Click here to read the full fund letter.",DXCM
92,2023-01-22,"Headline: Ranking The Diversified Healthcare Giants, source:SeekingAlpha, summary: The Top Six Healthcare Products and Service companies are some of the most popular investments in the market. Read more to see how giants rank.",DXCM
93,2023-01-24,"Headline: Dexcom Schedules Fourth Quarter and Full Year 2022 Earnings Release and Conference Call for February 9, 2023 at 4:30 p.m. Eastern Time, source:Yahoo, summary: SAN DIEGO, January 24, 2023--DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its fourth quarter and full year 2022 financial results after market close on Thursday, February 9, 2023. Management will hold a conference call to review the company's fourth quarter and full year 2022 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on the Dexcom investor relations website a",DXCM
94,2023-01-25,"Headline: Masimo's (MASI) Patient Monitoring Devices Favored by New Study, source:Yahoo, summary: Masimo's (MASI) patient monitoring devices continue to aid researchers in their assessment of different ventilatory strategies for brain oxygenation during thoracoscopic surgery.",DXCM
95,2023-01-27,"Headline: DexCom (DXCM) Gains But Lags Market: What You Should Know, source:Yahoo, summary: DexCom (DXCM) closed the most recent trading day at $106.72, moving +0.07% from the previous trading session.",DXCM
96,2023-01-28,"Headline: ClearBridge Global Growth Strategy Q4 2022 Portfolio Manager Commentary, source:SeekingAlpha, summary: During the fourth quarter, the ClearBridge Global Growth Strategy outperformed its MSCI ACWI benchmark. Click here to read the full fund letter.",DXCM
97,2023-01-29,"Headline: Tracking Baillie Gifford's 13F Portfolio - Q4 2022 Update, source:SeekingAlpha, summary: Baillie Giffordâs 13F portfolio value decreased from ~$96.99B to ~$95.96B this quarter. Click here for a detailed analysis.",DXCM
98,2023-01-30,"Headline: Op-ed: Keep an eye on medical technology and alternative energy sectors, source:CNBC, summary: Investors should keep a close eye on stocks in the medical technology and alternative energy sectors. By contrast, consumer staples may be in for a struggle.",DXCM
99,2023-02-02,"Headline: DexCom (DXCM) Gains But Lags Market: What You Should Know, source:Yahoo, summary: DexCom (DXCM) closed the most recent trading day at $108.03, moving +0.3% from the previous trading session.",DXCM
100,2023-02-03,"Headline: 2 Unstoppable Growth Stocks to Buy in 2023 and Beyond, source:Yahoo, summary: Last year's bear market made many victims among even the most prominent corporations although growth stocks fared even worse than other categories of equities.  Among this small group of outperformers are two healthcare leaders: biotech giant Vertex Pharmaceuticals (NASDAQ: VRTX) and medical device expert DexCom (NASDAQ: DXCM).  Let's consider why Vertex Pharmaceuticals and DexCom are excellent stocks to buy.",DXCM
101,2023-02-06,"Headline: DexCom (DXCM) to Report Q4 Earnings: What's in the Cards?, source:Yahoo, summary: DexCom's (DXCM) fourth-quarter results are likely to reflect rising global awareness of its real-time CGM.",DXCM
102,2023-02-07,"Headline: 2 Stock-Split Stocks to Buy Without Hesitation in 2023, source:Yahoo, summary: While stock splits aren't value-creating vehicles per se, these events can allow more investors access to stocks that otherwise have risen to such steep prices that buying even one or two shares may be out of reach.  There were several well-known stock splits that took place in 2022, and the current market environment has discounted some of these companies even further.  If you're bargain-hunting for wonderful businesses that fit this bill in the 2023 market environment, here are two recent stock-split stocks that are primed to deliver sustainable growth for investors in the next decade and beyond., Headline: DexCom Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: No summary, Headline: Notable earnings after Thursday`s close, source:Seeking Alpha, summary: No summary",DXCM
103,2023-02-08,"Headline: Top 5 4th Quarter Trades of JAG CAPITAL MANAGEMENT, LLC, source:GuruFocus, summary: No summary, Headline: DarioHealth announces agreement with DexCom, source:Seeking Alpha, summary: No summary, Headline: Will Ferrell, Alicia Silverstone star in Super Bowl ads, source:Associated Press, The, summary: No summary, Headline: GLOBAL BRIEFING: US ""not looking for conflict"" with China, says Biden, source:Alliance News, summary: No summary, Headline: DexCom options imply 6.0% move in share price post-earnings, source:Thefly.com, summary: No summary, Headline: DexCom reports Q4 EPS 22c, consensus 27c, source:Thefly.com, summary: No summary, Headline: DexCom sees FY23 revenue of $3.35B-$3.49B, consensus $3.47B, source:Thefly.com, summary: No summary, Headline: DexCom Non-GAAP EPS of $0.34 beats by $0.06, revenue of $815.2M in-line, source:Seeking Alpha, summary: No summary, Headline: DexCom Inc. stock falls Thursday, underperforms market, source:MarketWatch, summary: No summary, Headline: DexCom up 4% in after-hours trading on quarterly bottom line beat, source:Seeking Alpha, summary: No summary",DXCM
104,2023-02-09,"Headline: Fly Intel: After-Hours Movers, source:Thefly.com, summary: No summary, Headline: Dexcom (DXCM) Receives a Buy from BTIG, source:TipRanks, summary: No summary, Headline: Notable companies reporting after market close, source:Thefly.com, summary: No summary, Headline: DexCom: Q4 Earnings Snapshot, source:Associated Press, The, summary: No summary, Headline: DexCom looks forward to G7 system launch after 2022 profit jump, source:Alliance News, summary: No summary, Headline: Dexcom Reports Fourth Quarter and Fiscal Year 2022 Financial Results, source:Yahoo, summary: SAN DIEGO, February 09, 2023--Dexcom Reports Fourth Quarter and Fiscal Year 2022 Financial Results, Headline: DexCom, Inc. (DXCM) Q4 2022 Earnings Call Transcript, source:SeekingAlpha, summary: DexCom, Inc. (NASDAQ:NASDAQ:DXCM) Q4 2022 Earnings Conference Call February 9, 2023 4:30 PM ETCompany ParticipantsSean Christensen - Vice President of Finance & Investor RelationsJereme..., Headline: DexCom (DXCM) Tops Q4 Earnings and Revenue Estimates, source:Yahoo, summary: DexCom (DXCM) delivered earnings and revenue surprises of 30.77% and 0.02%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?, Headline: Hot Stocks: SPOT climbs on activist interest; DXCM, AYX rise on earnings; MGA drops, source:Seeking Alpha, summary: No summary, Headline: DexCom (DXCM) Q4 2022 Earnings Call Transcript, source:Yahoo, summary: Image source: The Motley Fool.  DexCom (NASDAQ: DXCM)Q4 2022 Earnings CallFeb 09, 2023, 4:30 p.m. ETContents:  Prepared Remarks Questions and Answers Call Participants  Prepared Remarks:  OperatorLadies and gentlemen, welcome to the Dexcom fourth quarter 2022 earnings release conference call., Headline: What You Missed On Wall Street On Friday, source:Thefly.com, summary: No summary, Headline: DexCom Inc. stock rises Friday, outperforms market, source:MarketWatch, summary: No summary",DXCM
105,2023-02-10,"Headline: Lyft, DexCom, Expedia, Spotify, and More of Today’s Stock Market Movers, source:MarketWatch, summary: Lyft issues a first-quarter revenue forecast below analysts' expectations; Spotify rises after ValueAct Capital Management secures a stake in the..., Headline: DexCom price target raised to $125 from $114 at Cowen, source:Thefly.com, summary: No summary, Headline: Stocks making the biggest premarket moves: Lyft, Expedia, Yelp and more, source:CNBC, summary: These are the stocks posting the largest moves in the premarket., Headline: Early notable gainers among liquid option names on February 10th, source:Thefly.com, summary: No summary, Headline: Hillstream, Lixte top healthcare gainers; Phathom, Sensus lead losers` pack, source:Seeking Alpha, summary: No summary, Headline: John Travolta, Adam Driver star in Super Bowl ads, source:Associated Press, The, summary: No summary, Headline: DexCom continues earnings boost as it prepares to launch new glucose device; up 10%, source:Seeking Alpha, summary: No summary, Headline: What You Missed On Wall Street This Morning, source:Thefly.com, summary: No summary, Headline: DexCom (DXCM) Q4 Earnings Beat Estimates, Volumes Remain Strong, source:Yahoo, summary: DexCom's (DXCM) fourth-quarter results reflect strong domestic and international revenue growth on the back of its real-time Continuous Glucose Monitoring system., Headline: Dexcom, A Top 10% Profit Machine, Just Reported Skyrocketing Earnings, source:Yahoo, summary: Dexcom stock rose Friday after beating fourth-quarter sales and earnings expectations and reiterating its 2023 sales outlook., Headline: PayPal, DexCom rise; Expedia, Lyft fall, source:Associated Press, The, summary: No summary, Headline: NEW YORK MARKET CLOSE: Tech shares struggle but Dow and S&P rise, source:Alliance News, summary: No summary, Headline: IBD Stock Of The Day Dexcom Bounds Off A New Entry After Topping Bullish Calls, source:Yahoo, summary: Dexcom stock is Friday's IBD Stock Of The Day. Shares are bounding off their 50-day line after the diabetes devices giant beat views., Headline: Cramer's lightning round: Triton International is not a buy, source:CNBC, summary: ""Mad Money"" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.",DXCM
106,2023-02-11,"Headline: Super Bowl spotlight will include Apple, DraftKings, GM and Diageo, source:Seeking Alpha, summary: No summary, Headline: Wall Street Breakfast: What Moved Markets, source:SeekingAlpha, summary: Listen on the go! A daily podcast of Wall Street Breakfast will be available this morning on Seeking Alpha, iTunes, Stitcher and Spotify., Headline: DexCom Full Year 2022 Earnings: EPS Misses Expectations, source:Yahoo, summary: DexCom ( NASDAQ:DXCM ) Full Year 2022 Results Key Financial Results Revenue: US$2.91b (up 19% from FY 2021). Net...",DXCM
107,2023-02-12,"Headline: Barclays Remains a Hold on Dexcom (DXCM), source:TipRanks, summary: No summary, Headline: Doja Cat, John Travolta, Ben Affleck star in Super Bowl ads, source:Associated Press, The, summary: No summary",DXCM
108,2023-02-13,"Headline: DexCom price target raised to $110 from $103 at Barclays, source:Thefly.com, summary: No summary, Headline: DexCom: G7 CGM System to be covered for Medicare beneficiaries, source:Thefly.com, summary: No summary, Headline: DexCom`s G7 receives CMS approval, says Piper Sandler, source:Thefly.com, summary: No summary, Headline: Robert W. Baird Keeps Their Buy Rating on Dexcom (DXCM), source:TipRanks, summary: No summary, Headline: 2 Top Healthcare Stocks to Buy for the Long Haul, source:Yahoo, summary: The healthcare industry is booming, and this presents no shortage of opportunities to invest in promising businesses., Headline: Dexcom G7 Continuous Glucose Monitoring System Will Be Available to Medicare Beneficiaries at Launch, source:Yahoo, summary: SAN DIEGO, February 13, 2023--Dexcom G7 Continuous Glucose Monitoring System Will be Available to Medicare Beneficiaries at Launch, Headline: 2 Growth Stocks That Could Help Make You a Fortune, source:Yahoo, summary: Looking beyond share price, you don't have to search hard to find compelling businesses with abundant growth opportunities that boast strong financials to boot.  DexCom (NASDAQ: DXCM) is one of the world's leading developers and manufacturers of continuous glucose monitoring (CGM) devices, which help people monitor and manage their blood sugar levels.  While primarily used by the type 1 diabetes population, and increasingly, those with type 2 diabetes, there could be use cases for these products in individuals with prediabetes as well., Headline: DexCom Inc. stock rises Monday, still underperforms market, source:MarketWatch, summary: Shares of DexCom Inc. inched 0.33% higher to $118.28 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P..., Headline: Dow Jones Leader Salesforce Headlines 4 Stocks In Or Near Buy Zone, source:Yahoo, summary: Dow Jones software titan Salesforce is one of the top stocks to buy and watch in today's stock market rally. CRM stock neared a new entry.",DXCM
109,2023-02-14,"Headline: Top 5 4th Quarter Trades of Atika Capital Management LLC, source:GuruFocus, summary: No summary, Headline: June 2024 Options Now Available For DexCom (DXCM), source:Stock Options Channel, summary: No summary, Headline: DexCom Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: Shares of DexCom Inc. inched 0.23% higher to $118.55 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500...",DXCM
110,2023-02-15,"Headline: DexCom Inc. stock rises Wednesday, outperforms market, source:MarketWatch, summary: Shares of DexCom Inc. advanced 1.37% to $120.17 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P...",DXCM
111,2023-02-16,"Headline: DexCom: Multiple Catalyst In FY 2023, source:SeekingAlpha, summary: DexCom has implemented a bridge program for early adopters and is making steady progress toward its goal of G7 coverage. Click here to read why DXCM stock is a Buy., Headline: DexCom Inc. stock falls Thursday, underperforms market, source:MarketWatch, summary: Shares of DexCom Inc. slid 2.42% to $117.26 Thursday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index...",DXCM
112,2023-02-17,"Headline: Does DexCom (DXCM) Have a Long Runway for Growth?, source:Yahoo, summary: Baron Funds, an investment management company, released its “Baron Small Cap Fund” fourth-quarter 2022 investor letter. A copy of the same can be downloaded here. The fund was 4.24% up in the fourth quarter compared to a 4.13% return for the Russell 2000 Growth Index and a 7.56% return for the S&P 500 Index. For 2022, […], Headline: DexCom Inc. stock underperforms Friday when compared to competitors, source:MarketWatch, summary: Shares of DexCom Inc. slid 2.13% to $114.76 Friday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones..., Headline: The Week On Wall Street - Economic Purgatory, source:SeekingAlpha, summary: Except for Jobs, economic data dictates the economy is in a state of contraction, while Inflation remains sticky. Read more here.",DXCM
113,2023-02-18,"Headline: Deere Leads 5 Stocks With Hot Products Near Buy Points, source:Yahoo, summary: Deere, fresh off Friday's strong earnings move, leads this weekend's watch list of 5 stocks near buy points.",DXCM
114,2023-02-19,"Headline: 2 Healthcare Stocks You Can Buy and Hold for the Next Decade, source:Yahoo, summary: From medical devices to life-saving medicines and treatments, there's a simple reason why healthcare companies perform well against a wide range of economic backdrops and market environments.  Not only are the best healthcare stocks known for their steady growth in a variety of markets, but these businesses can present a tempting buying proposition for long-term investors.  If you're looking to add more healthcare stocks to your buy basket this month, here are two no-brainer choices to consider when you do., Headline: 2 No-Brainer Growth Stocks to Buy Right Now, source:Yahoo, summary: Vertex Pharmaceuticals (NASDAQ: VRTX) has amassed a profitable and high-revenue growth business around a relatively small portfolio of drugs.  While the addressable market for Vertex's existing portfolio of cystic fibrosis drugs is massive -- management estimates that as many as 20,000 people globally could benefit from the company's products but are not yet taking them -- and additional indications for these drugs are expanding its patient population, the company is looking to new sources of growth.  It currently has an impressive pipeline of products spanning disease areas ranging from rare blood disorders to type 1 diabetes to acute pain.",DXCM
115,2023-02-20,"Headline: 2 Exceptional Growth Stocks Billionaires Keep Buying With Both Hands, source:Yahoo, summary: A poor performance from the broad market didn't stop these billionaire hedge fund managers from placing big bets on three supercharged growth stocks., Headline: Why Investors Need to Take Advantage of These 2 Medical Stocks Now, source:Yahoo, summary: Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.",DXCM
116,2023-02-21,"Headline: 3 Healthcare Stocks to Buy and Hold for the Next 10 Years, source:Yahoo, summary: The healthcare industry has long proven itself to be a resilient place for investors to park their cash.  Vertex Pharmaceuticals (NASDAQ: VRTX) has continued to report explosive financial growth from its core portfolio of products, all while expanding its pipeline into new disease areas ripe for disruption.  It's delivered a total return of 24% over the past year, compared to the S&P 500's negative return of 7% in that same period., Headline: Becton Dickinson & Co. stock outperforms competitors despite losses on the day, source:MarketWatch, summary: Shares of Becton Dickinson & Co. slid 2.05% to $239.50 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P..., Headline: DexCom Inc. stock falls Tuesday, still outperforms market, source:MarketWatch, summary: Shares of DexCom Inc. sank 0.65% to $114.01 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index..., Headline: Baird points to elements of Apple report making it `less worried` about DexCom, source:Thefly.com, summary: No summary, Headline: DexCom selloff on Apple article should be bought, says Oppenheimer, source:Thefly.com, summary: No summary, Headline: Dexcom G6 Continuous Glucose Monitoring System Launches in Singapore, source:Yahoo, summary: SINGAPORE, February 22, 2023--Dexcom, Inc. (NASDAQ:DXCM), a global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, announced today the launch of its Dexcom G6 CGM System in Singapore for people with diabetes ages two years and older, including pregnant women, and the appointment of DKSH Singapore Pte Ltd as sales, marketing, and distribution service provider.",DXCM
117,2023-02-22,"Headline: Dexcom Showcases Accuracy, Simplicity and Connectivity of Its CGM Portfolio at ATTD Conference as Access to CGM Expands Globally, source:Yahoo, summary: SAN DIEGO, February 22, 2023--Dexcom Showcases Accuracy, Simplicity and Connectivity of its CGM Portfolio at ATTD Conference as Access to CGM Expands Globally, Headline: Apple hits breakthroughs in glucose monitoring project, Bloomberg reports, source:Thefly.com, summary: No summary, Headline: Diabetes management stocks slide on report of tech giant`s breakthroughs, source:Thefly.com, summary: No summary, Headline: Apple nears bid to shake up glucose monitoring market ��� Bloomberg, source:Seeking Alpha, summary: No summary, Headline: DexCom Inc. stock falls Wednesday, underperforms market, source:MarketWatch, summary: Shares of DexCom Inc. slipped 2.07% to $111.65 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500..., Headline: Health Care Down Slightly as Apple, Amazon Step Up Health Efforts -- Health Care Roundup, source:MarketWatch, summary: Health-care companies fell slightly as competition from Silicon Valley mounted. Shares of medical-device maker Dexcom fell after reports that Apple may add a..., Headline: Dexcom drops on report that Apple has made glucose tracking breakthrough, source:CNBC, summary: A new breakthrough by Apple could be bad news for medical device company Dexcom. With CNBC's Melissa Lee and the Fast Money traders, Karen Finerman, Dan Nathan, Courtney Garcia and Guy Adami., Headline: Dexcom Slumps As A New Rival Reportedly Arrives On Scene: Apple, source:Yahoo, summary: Dexcom stock slumped Wednesday on a report Apple is working to add a blood glucose monitor to its popular Apple Watch.",DXCM
118,2023-02-23,"Headline: Frank Sands` Top 4th-Quarter Trades, source:GuruFocus, summary: No summary, Headline: Dexcom Announces Upcoming Conference Presentations, source:Yahoo, summary: SAN DIEGO, February 23, 2023--DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the following upcoming investor conferences:, Headline: Becton Dickinson & Co. stock underperforms Thursday when compared to competitors, source:MarketWatch, summary: Shares of Becton Dickinson & Co. shed 0.28% to $239.72 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the..., Headline: DexCom Inc. stock rises Thursday, still underperforms market, source:MarketWatch, summary: Shares of DexCom Inc. inched 0.20% higher to $111.87 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the...",DXCM
119,2023-02-24,"Headline: Apple: Still Early For The Holy Grail, source:SeekingAlpha, summary: Apple continues working on turning the Apple Watch into a medical device. Meanwhile, AAPL stock is already priced for a Holy Grail new product. Read more here., Headline: 2 Stock-Split Stocks with Explosive Potential to Buy in 2023, source:Yahoo, summary: Stock splits don't actually do anything to augment the values of the companies that perform them, but they can make a stock that has reached a particularly bloated price more accessible to the average investor again.  2022 saw its fair share of stock splits from large companies across a range of sectors.  Amazon (NASDAQ: AMZN) underwent a 20-for-1 stock split on June 3, 2022., Headline: Better Buy: Abbott Laboratories or DexCom Stock?, source:Yahoo, summary: According to MarketStudyReport, a market research firm,  the global diabetes care devices market was $23.3 billion in 2022 and is projected to reach $32.7 billion by 2028, representing a compound annual growth rate of 4.95% over this period.  Abbott Laboratories (NYSE: ABT) and DexCom (NASDAQ: DXCM) are both poised to benefit from increased spending on diabetes care devices as they manufacture continuous glucose monitoring devices used by diabetes patients.  Abbott Laboratories stock is down over 4% in 2023 and more than 10% over the past 12 months., Headline: DexCom Inc. stock falls Friday, underperforms market, source:MarketWatch, summary: Shares of DexCom Inc. slid 1.59% to $110.09 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index..., Headline: Baron Small Cap Fund Q4 2022 Quarterly Letter, source:SeekingAlpha, summary: Baron Small Cap Fund (the âFundâ) was up 4.24% (Institutional Shares) in the fourth quarter of 2022. Click here to read the full fund letter.",DXCM
120,2023-02-27,"Headline: Becton Dickinson & Co. stock outperforms competitors despite losses on the day, source:MarketWatch, summary: Shares of Becton Dickinson & Co. slumped 0.43% to $236.89 Monday, on what proved to be an all-around positive trading session for the stock market, with the..., Headline: DexCom Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: Shares of DexCom Inc. inched 0.45% higher to $110.58 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P..., Headline: Start Putting Together Your Shopping List For Beaten-Down Tech Stocks, source:SeekingAlpha, summary: Put together a stock shopping list. You have time to understand the stocks you are investing in., Headline: 2 ���Strong Buy��� Stocks That Billionaire Israel Englander Is Making Huge Bets On, source:TipRanks, summary: No summary",DXCM
121,2023-02-28,"Headline: Billionaire Israel Englander Is Making Huge Bets on These 2 ���Strong Buy` Stocks, source:TipRanks, summary: No summary, Headline: What Do Sanofi And Dexcom See In DarioHealth That The Market Is Missing?, source:Yahoo, summary: DarioHealth (NASDAQ: DRIO) Partners With Dexcom (NASDAQ: DXCM) The Global Leader in Continuous Glucose Monitoring (CGM) To Integrate Dario's Multi-Chronic Condition Platform., Headline: Should Abbott and DexCom Investors Be Worried About Apple's Latest News?, source:Yahoo, summary: Abbott Laboratories (NYSE: ABT) and DexCom (NASDAQ: DXCM) enjoy symbiotic relationships with Apple (NASDAQ: AAPL).  The two companies' popular continuous glucose monitoring (CGM) devices used by many patients with diabetes connect to iPhones and Apple Watches.  Bloomberg reported last week about one of Apple's major development efforts., Headline: Becton Dickinson & Co. stock falls Tuesday, underperforms market, source:MarketWatch, summary: Shares of Becton Dickinson & Co. dropped 0.99% to $234.55 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P..., Headline: 2 “Strong Buy” Stocks That Billionaire Israel Englander Is Making Huge Bets On, source:Yahoo, summary: After the year’s early rally appeared to hit a brick wall in recent times, the markets seem uncertain which direction to take next, making the seesawing conditions not easy for investors to navigate. Against such a backdrop, maybe the best solution for investors is to follow in the footsteps of legendary Wall Street names - ones like Israel Englander. The Millennium Management Chairman and CEO founded the hedge fund in 1989 with $35 million and now the firm is an almost $53 billion going concern",DXCM
122,2023-03-01,"Headline: DexCom Inc. stock outperforms competitors despite losses on the day, source:MarketWatch, summary: Shares of DexCom Inc. slid 0.23% to $110.76 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones..., Headline: DexCom rises as Medicare updates coverage for continuous glucose monitors, source:Seeking Alpha, summary: No summary",DXCM
123,2023-03-02,"Headline: DexCom CEO sells $4.23M in common stock, source:Thefly.com, summary: No summary, Headline: Early notable gainers among liquid option names on March 2nd, source:Thefly.com, summary: No summary, Headline: Tandem Diabetes: Top-Line Growth Remarkable, Not At 0.04% FCF Yield, source:SeekingAlpha, summary: Tandem Diabetes achieved remarkable top-line growth coupled with pump shipments. Check out why I rate TNDM stock a Hold at this time., Headline: Where to Invest $1,000 in a 2023 Nasdaq Bear Market, source:Yahoo, summary: The bear market of the past year has kept investors on their toes.  While stocks across a variety of sectors feel the pain, few have been hit as hard as those on the growth-centric Nasdaq Composite index.  Many of these growth stocks have seen some improvement in 2023., Headline: DexCom Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: Shares of DexCom Inc. advanced 9.46% to $121.24 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500..., Headline: Dexcom Nears Breakout On A Surprise Medicare Decision For Its Devices, source:Yahoo, summary: Dexcom stock popped Thursday after CMS said it would cover continuous glucose monitors for a broader group of type 2 diabetics.",DXCM
124,2023-03-03,"Headline: Analysts Offer Insights on Healthcare Companies: Selecta Biosciences (SELB), Dexcom (DXCM) and Zai Lab (ZLAB), source:TipRanks, summary: No summary, Headline: CMS earlier Basal coverage approval adds confidence for DexCom, says BofA, source:Thefly.com, summary: No summary, Headline: Analysts Offer Insights on Healthcare Companies: Dexcom (DXCM), Veru (VERU) and Gilead Sciences (GILD), source:TipRanks, summary: No summary, Headline: Analysts` Opinions Are Mixed on These Healthcare Stocks: Amgen (AMGN) and Dexcom (DXCM), source:TipRanks, summary: No summary, Headline: 1 High-Flying Growth Stock With 19% Upside, According to Wall Street, source:Yahoo, summary: Medical device specialist DexCom (NASDAQ: DXCM) has been on fire over the past year, significantly outperforming the broader market.  The healthcare company can thank several tailwinds for its performance, including the continued adoption of the technology it has helped pioneer -- continuous glucose monitoring (CGM) -- and the launch of new products.  Should investors follow the Street's advice and buy DexCom's shares?, Headline: DexCom Inc. stock rises Friday, still underperforms market, source:MarketWatch, summary: Shares of DexCom Inc. rallied 1.39% to $122.92 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index..., Headline: Here's Why DexCom (NASDAQ:DXCM) Has Caught The Eye Of Investors, source:Yahoo, summary: It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story..., Headline: DexCom (DXCM) Gains But Lags Market: What You Should Know, source:Yahoo, summary: DexCom (DXCM) closed the most recent trading day at $122.92, moving +1.39% from the previous trading session.",DXCM
125,2023-03-05,"Headline: DexCom down more than 7% after FDA gives nod to Abbott CGM sensors, source:Thefly.com, summary: No summary",DXCM
126,2023-03-06,"Headline: Video: S&P 500 Movers: DXCM, LUMN, source:Market News Video, summary: No summary, Headline: Video: Nasdaq 100 Movers: DXCM, ENPH, source:Market News Video, summary: No summary, Headline: DexCom put volume heavy and directionally bearish, source:Thefly.com, summary: No summary, Headline: DexCom slips as Abbott wins FDA nod for CGM integration, source:Seeking Alpha, summary: No summary, Headline: 5 Stocks That Powered Nasdaq ETF Last Week, source:Yahoo, summary: The tech-heavy Nasdaq Composite Index outperformed last week, gaining 2.6%, while the S&P 500 and the Dow Jones were up 1.9% and 1.7%, respectively., Headline: DexCom Inc. stock underperforms Monday when compared to competitors, source:MarketWatch, summary: Shares of DexCom Inc. shed 7.87% to $113.25 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index..., Headline: Dexcom Pummeled On A New FDA Clearance For Key Rival Abbott Laboratories, source:Yahoo, summary: Dexcom stock toppled Monday after the FDA cleared Abbott Laboratories to pair its body-worn glucose monitors with automated insulin pumps.",DXCM
127,2023-03-07,"Headline: BofA says buy DexCom on weakness after Abbott`s Libre gets pump integration, source:Thefly.com, summary: No summary, Headline: What Makes DexCom (DXCM) an Attractive Investment Bet?, source:Yahoo, summary: ClearBridge Investments, an investment management company, released its “ClearBridge Large Cap Growth Strategy” fourth quarter 2022 investor letter. A copy of the same can be downloaded here. In the fourth quarter, the strategy outperformed its benchmark, the Russell 1000 Growth Index. The strategy gained in seven out of nine sectors it invested in the quarter on […], Headline: DexCom Inc. stock rises Tuesday, outperforms market, source:MarketWatch, summary: Shares of DexCom Inc. inched 0.49% higher to $113.81 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P...",DXCM
128,2023-03-08,"Headline: DexCom pullback on Abbott news a buying opportunity, says Jefferies, source:Thefly.com, summary: No summary, Headline: DexCom Inc. stock underperforms Wednesday when compared to competitors, source:MarketWatch, summary: Shares of DexCom Inc. dropped 0.94% to $112.74 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500..., Headline: DexCom Inc. stock outperforms market despite losses on the day, source:MarketWatch, summary: No summary",DXCM
129,2023-03-09,"Headline: Want to Get Richer? 2 Top Stocks to Buy Now and Hold Forever, source:Yahoo, summary: You don't need to have a lot of cash on hand to start investing in the stock market.  Marketed as 60% smaller than its predecessor, with the fastest warm-up time of any such device on the market, and as part of the most-covered and reimbursed CGM brand commercialized to date, the G7 should be the latest in a long line of strong growth catalysts for DexCom., Headline: 2 Top Stocks to Buy in March and Hold Forever, source:Yahoo, summary: If you're looking for more great stocks to add to your portfolio this month, you don't have to look far to find quality businesses with compelling growth stories.  Provided you have the capital on hand to invest right now that you can put into your portfolio and leave alone for the next few years, even the current choppy waters of the market are still presenting investors with wonderful opportunities to buy great companies.  Here are two names to consider adding to your portfolio in the near future and holding for years., Headline: DexCom (DXCM) Stock Moves -0.59%: What You Should Know, source:Yahoo, summary: In the latest trading session, DexCom (DXCM) closed at $112.08, marking a -0.59% move from the previous day.",DXCM
130,2023-03-10,"Headline: DexCom Inc. stock falls Friday, underperforms market, source:MarketWatch, summary: Shares of DexCom Inc. slid 3.85% to $107.77 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index...",DXCM
131,2023-03-12,"Headline: Silicon Valley Bank signed exclusive banking deals with some clients, leaving them unable to diversify, source:CNBC, summary: Silicon Valley Bank required some clients to agree to exclusivity clauses, disabling them from diversifying where they held their money, SEC records show.",DXCM
132,2023-03-13,"Headline: DexCom has no material exposure to developments at Silicon Valley Bank, source:Thefly.com, summary: No summary, Headline: DexCom Comments on SVB Relationship, source:Yahoo, summary: SAN DIEGO, March 13, 2023--DexCom, Inc. (NASDAQ: DXCM), today issued the following statement in response to speculation following the developments at Silicon Valley Bank, including a recent CNBC article:",DXCM
133,2023-03-15,"Headline: DexCom Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: Shares of DexCom Inc. inched 0.49% higher to $113.72 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P..., Headline: DexCom: Riding The Growth Wave, source:SeekingAlpha, summary: DexCom has built itself an impressive market position against large competitors in the diabetes space. Click here to read my most recent analysis of DXCM stock., Headline: DexCom (DXCM) Gains As Market Dips: What You Should Know, source:Yahoo, summary: DexCom (DXCM) closed the most recent trading day at $113.72, moving +0.49% from the previous trading session.",DXCM
134,2023-03-16,"Headline: DexCom Stock Gets A Composite Rating Upgrade After 4 Up Days, source:Yahoo, summary: The IBD SmartSelect Composite Rating for DexCom rose from 94 to 97 Thursday.  The new score means the company is now outperforming 97% of all stocks in terms of the most important fundamental and technical stock-picking criteria.  DexCom is currently forming a consolidation, with a 125.65 buy point., Headline: DexCom Inc. stock rises Thursday, still underperforms market, source:MarketWatch, summary: Shares of DexCom Inc. inched 0.74% higher to $114.56 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the...",DXCM
135,2023-03-17,"Headline: DexCom Inc. stock outperforms competitors despite losses on the day, source:MarketWatch, summary: Shares of DexCom Inc. slipped 0.55% to $113.93 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index...",DXCM
136,2023-03-18,"Headline: Why Nick Jonas is raising awareness for diabetes at SXSW, source:Yahoo, summary: Superstar recording artist Nick Jonas shares his experience with diabetes and why he's using his platform to improve access to diabetes care. Nick joins Yahoo Finance Senior Reporter Allie Garfinkle from SXSW in Austin, TX to discuss how health technology like continuous glucose monitoring (CGM) is easing the burden of managing diabetes.  Watch as Nick opens up about his partnership with DexCom (DXCM), fatherhood, and his struggle with diabetes.",DXCM
137,2023-03-20,"Headline: Is DexCom (DXCM) Stock Undervalued?, source:Yahoo, summary: Brown Capital Management, an investment management company, released its “The Brown Capital Management Mid Company Fund” fourth quarter 2022 investor letter. A copy of the same can be downloaded here. The Mid Company Fund returned 5.43% in the quarter compared to a 6.90% return for the Russell Midcap Growth Index. For the full year, the fund […], Headline: Elliott Wave Technical Analysis: DexCom Inc., source:TalkMarkets, summary: No summary, Headline: Abbott Labs: Steadily Getting Back To Normal, source:SeekingAlpha, summary: Abbott has had a crazy couple of years, with a formula recall and a COVID testing boom. Find out why I rate ABT stock a hold., Headline: How to Find Strong Medical Stocks Slated for Positive Earnings Surprises, source:Yahoo, summary: Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP., Headline: DexCom Inc. stock rises Monday, outperforms market, source:MarketWatch, summary: Shares of DexCom Inc. rallied 2.88% to $117.21 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...",DXCM
138,2023-03-21,"Headline: DexCom announces expanded coverage for G6 CGM System in Manitoba, source:Thefly.com, summary: No summary, Headline: Manitoba Becomes a Provincial Trailblazer in Providing Simplified Access to Advanced Glucose Monitors, source:Yahoo, summary: BURNABY, British Columbia, March 21, 2023--Dexcom, Inc. (NASDAQ: DXCM), a global leader in real-time continuous glucose monitoring (rtCGM) for people with diabetes, announced that its Dexcom G6 CGM System will be available to people of all ages with type 1 and type 2 diabetes in Manitoba who meet eligibility criteria., Headline: DexCom Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: Shares of DexCom Inc. rose 1.51% to $118.98 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500..., Headline: DexCom (DXCM) Outpaces Stock Market Gains: What You Should Know, source:Yahoo, summary: DexCom (DXCM) closed the most recent trading day at $118.98, moving +1.51% from the previous trading session.",DXCM
139,2023-03-22,"Headline: DexCom Inc. stock underperforms Wednesday when compared to competitors, source:MarketWatch, summary: Shares of DexCom Inc. shed 3.35% to $115.00 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index..., Headline: DexCom Inc. stock underperforms Thursday when compared to competitors, source:MarketWatch, summary: No summary",DXCM
140,2023-03-23,"Headline: Have $1,000? 2 Stock-Split Companies to Add to Your Buy Basket Right Now., source:Yahoo, summary: Modern investing has made buying into great companies more accessible than ever, particularly with so many brokerages offering fractional shares.  Another way that high-flying stocks can become more accessible to the average investor is through stock splits.  If you have $1,000 to put into the market right now, here are two companies that recently underwent stock splits to consider holding for years.",DXCM
141,2023-03-24,"Headline: DexCom, Inc.'s (NASDAQ:DXCM) Stock Has Fared Decently: Is the Market Following Strong Financials?, source:Yahoo, summary: DexCom's (NASDAQ:DXCM) stock up by 2.7% over the past three months. Since the market usually pay for a company’s..., Headline: Dexcom (DXCM) Launches G6 Glucose Monitoring System in Canada, source:Yahoo, summary: Dexcom (DXCM) announces the availability of standard of care in diabetes management - G6 CGM system - for type 1 and 2 patients with basal and bolus insulin or using an insulin pump in Canada., Headline: Dexcom Stock Option Trade Could Return $465 While Risking Just $35, source:Yahoo, summary: From a prime commercial ad spot during the Super Bowl to this year's star diabetes solutions and glucose monitoring systems, Dexcom returns to my list of stocks that have been excellent to trade using options.  Dexcom sits with a Composite Rating in IBD of 96, ranking second in its industry group according to IBD Stock Checkup., Headline: DexCom Inc. stock falls Friday, underperforms market, source:MarketWatch, summary: Shares of DexCom Inc. shed 0.36% to $114.09 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...",DXCM
142,2023-03-25,"Headline: Nasdaq Bear Market: 2 Growth Stocks to Buy That Keep Bucking the Trend, source:Yahoo, summary: The past 15 months haven't been easy for growth stock investors.  The Nasdaq Composite index has fallen a disappointing 25% since the beginning of 2022, making this an unusually long bear market.  You don't need an economics degree to see that every bear market in history has been wiped away by subsequent recoveries.",DXCM
143,2023-03-26,"Headline: Global continuous glucose monitoring market to hit $32B by 2031 ��� report, source:Seeking Alpha, summary: No summary",DXCM
144,2023-03-27,"Headline: DexCom Q1 report can be a catalyst for shares, says Jefferies, source:Thefly.com, summary: No summary, Headline: DexCom Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: Shares of DexCom Inc. rallied 1.74% to $116.07 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...",DXCM
145,2023-03-28,"Headline: DexCom Inc. stock falls Tuesday, underperforms market, source:MarketWatch, summary: Shares of DexCom Inc. slipped 1.94% to $113.82 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index..., Headline: Why did Tandem Diabetes Care stock go down today?, source:Seeking Alpha, summary: No summary",DXCM
146,2023-03-29,"Headline: DexCom initiated with a Buy at UBS, source:Thefly.com, summary: No summary, Headline: Where Will DexCom Be in 1 Year?, source:Yahoo, summary: Diabetes-focused medical device specialist DexCom (NASDAQ: DXCM) has been successful thanks to its continuous glucose monitoring (CGM) devices that allow diabetes patients to check their blood glucose levels in real time.  While the growing adoption of this technology has generally bolstered its revenue, the company's top-line growth rates have dropped of late.  How will the next 12 months go for DexCom?, Headline: Street Wrap: Today`s Top 15 Upgrades, Downgrades, Initiations, source:Thefly.com, summary: No summary, Headline: DexCom Inc. stock rises Wednesday, still underperforms market, source:MarketWatch, summary: Shares of DexCom Inc. inched 0.13% higher to $113.96 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P..., Headline: UBS Initiates Coverage of DexCom (DXCM) with Buy Recommendation, source:Fintel, summary: nan",DXCM
147,2023-03-30,"Headline: DexCom Inc. stock rises Thursday, still underperforms market, source:MarketWatch, summary: Shares of DexCom Inc. inched 0.39% higher to $114.40 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P...",DXCM
148,2023-03-31,"Headline: Mednow Achieves Record Q2 2023 Financial Results with Quarterly Revenue of $11.3 Million; 17% Q/Q Revenue Growth and 466% Y/Y Revenue Growth; Adjusted EBITDA Improved 32% Y/Y; and Cash Flow from Operations Improved by 7% Q/Q, source:Business Wire, summary: No summary, Headline: 2 All-Weather Stocks to Buy Without Hesitation Right Now, source:Yahoo, summary: Despite near-term economic clouds, long-term investors can still find compelling buying opportunities., Headline: DexCom Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: Shares of DexCom Inc. rallied 1.56% to $116.18 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500..., Headline: DexCom (DXCM) Outpaces Stock Market Gains: What You Should Know, source:Yahoo, summary: DexCom (DXCM) closed the most recent trading day at $116.18, moving +1.56% from the previous trading session.",DXCM
149,2023-04-02,"Headline: Nick Jonas and Dexcom talk partnership, the future of diabetes management tech, source:Yahoo, summary: When Nick Jonas attended SXSW this year, it wasn't to perform – instead, it was to raise awareness about continuous glucose monitoring, or CGM, a technology that can provide real-time blood glucose readings to help manage diabetes., Headline: Fly Insider: Kohl`s, 89Bio among week`s notable insider trades, source:Thefly.com, summary: No summary",DXCM
150,2023-04-03,"Headline: Goldman leans to growth picks in either recession scenario, source:Seeking Alpha, summary: No summary, Headline: What Investors Need to Know About the Growing Digital Health Space, source:Nasdaq, summary: In this piece, we will look at how big the digital health space is, as well as who the major players are., Headline: DexCom Inc. stock underperforms Monday when compared to competitors, source:MarketWatch, summary: Shares of DexCom Inc. slumped 0.81% to $115.24 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...",DXCM
151,2023-04-04,"Headline: DexCom Inc. stock rises Tuesday, outperforms market, source:MarketWatch, summary: Shares of DexCom Inc. inched 0.35% higher to $115.64 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500...",DXCM
152,2023-04-05,"Headline: Dexcom Publishes Annual Sustainability Report, source:Yahoo, summary: SAN DIEGO, April 05, 2023--DexCom, Inc. (NASDAQ:DXCM), the leader in real-time continuous glucose monitoring (CGM) for people with diabetes, today released its annual Sustainability Report, which provides updates on key environmental, social, and governance (ESG) initiatives that are aligned with Dexcom’s core values and business strategy., Headline: 2 Explosive Growth Stocks to Buy in April, source:Yahoo, summary: With even the most tried-and-true companies across a wide selection of industries seeing share prices buckle in this environment, it's more important than ever to consider where you put your investing capital to work and ensure that the underlying businesses align with your portfolio goals and risk tolerance.  If you're on the hunt for two compelling businesses to add to your buy basket this month, here are two names to consider right now.  DexCom (NASDAQ: DXCM) continues to derive substantial revenue growth and profits from its market-leading portfolio of continuous glucose monitoring (CGM) devices., Headline: DexCom Inc. stock underperforms Wednesday when compared to competitors, source:MarketWatch, summary: Shares of DexCom Inc. shed 2.44% to $112.82 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...",DXCM
153,2023-04-06,"Headline: Abbott recalls millions of FreeStyle Libre glucose monitoring devices, source:Seeking Alpha, summary: No summary, Headline: Here’s Why DexCom (DXCM) Surged in Q4, source:Yahoo, summary: Aristotle Atlantic Partners, LLC, an investment advisor, released its “Focus Growth Strategy” fourth quarter 2022 investor letter. A copy of the same can be downloaded here. In the fourth quarter, Aristotle Atlantic’s Focus Growth strategy posted a return of 2.66% net of fees compared to a 2.20% return for the Russell 1000 Growth Index. Stock selection […], Headline: Dexcom Schedules First Quarter 2023 Earnings Release and Conference Call for April 27, 2023 at 4:30 p.m. Eastern Time, source:Yahoo, summary: SAN DIEGO, April 06, 2023--DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its first quarter 2023 financial results after market close on Thursday, April 27, 2023. Management will hold a conference call to review the company's first quarter 2023 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on the Dexcom investor relations website at investors.dexcom.com and will be, Headline: 3 No-Brainer Medical Device Stocks to Buy Right Now, source:Yahoo, summary: On top of that, labor shortages for hospital staff, tightened hospital spending, and supply chain issues slowed sales of medical equipment.  Edwards Lifesciences focuses on devices for critical care monitoring and to treat structural heart disease.  About 10 years ago, the company pioneered transcatheter heart valves (TAVR) that don't require open-heart surgery., Headline: DexCom Inc. stock underperforms Thursday when compared to competitors, source:MarketWatch, summary: Shares of DexCom Inc. sank 0.31% to $112.47 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...",DXCM
154,2023-04-08,"Headline: A Nasdaq Bull Market Is Coming: 2 Fantastic Stocks to Buy and Hold, source:Yahoo, summary: DexCom (NASDAQ: DXCM) has a leadership position in the diabetes care space thanks to its continuous glucose monitoring (CGM) devices, which track patients' glucose levels.  DexCom generated about 40% of that amount with its top line totaling just shy of $3 billion, up 20% from 2021.  A number of factors drove DexCom's continued growth, even amid increased competition in the diabetes care space.",DXCM
155,2023-04-10,"Headline: DexCom Inc. stock rises Monday, still underperforms market, source:MarketWatch, summary: Shares of DexCom Inc. inched 0.05% higher to $112.53 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...",DXCM
156,2023-04-11,"Headline: Elliott Wave Technical Analysis: DexCom Inc. - Tuesday, April 11, source:TalkMarkets, summary: No summary, Headline: DexCom Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: Shares of DexCom Inc. advanced 2.23% to $115.04 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500...",DXCM
157,2023-04-12,"Headline: 10-Year 10-Baggers, source:Seeking Alpha, summary: No summary, Headline: DexCom Inc. stock outperforms competitors despite losses on the day, source:MarketWatch, summary: Shares of DexCom Inc. shed 0.19% to $114.82 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index..., Headline: 10-Year 10-Baggers, source:SeekingAlpha, summary: In the Russell 1,000, 33 names are up more than 1,000% since April 12th, 2013. Over the same 10-year period, the S&P 500 tracking ETF (SPY) is up 211%.",DXCM
158,2023-04-13,"Headline: 3 Reasons to Hold DexCom (DXCM) Stock in Your Portfolio, source:Yahoo, summary: Investors continue to be optimistic about DexCom (DXCM) owing to its strong product portfolio., Headline: 2 Stocks That Turned $40,000 Into $1 Million in 10 Years, source:Yahoo, summary: Two stocks that have turned $40,000 investments into more than $1 million over the past decade are DexCom (NASDAQ: DXCM) and Tesla (NASDAQ: TSLA).  Diabetes is a growing concern for the healthcare industry as the disease is related to many other health problems.  An estimated 38% of the adult U.S. population has pre-diabetes, which in many cases will end up resulting in diabetes., Headline: DexCom Inc. stock rises Thursday, still underperforms market, source:MarketWatch, summary: Shares of DexCom Inc. rose 1.27% to $116.28 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500..., Headline: DexCom Stock Sets Up; Can It Catch Up To Company's Torrid Growth?, source:Yahoo, summary: After taking a detour from its torrid growth pace, DexCom is back on the fast lane. Can DexCom stock reflect that rapid growth?",DXCM
159,2023-04-14,"Headline: ClearBridge Large Cap Growth Strategy Q1 2023 Portfolio Manager Commentary, source:SeekingAlpha, summary: The ClearBridge Large Cap Growth Strategy outperformed its benchmark in the first quarter. Click here to read the full fund letter., Headline: DexCom Inc. stock falls Friday, underperforms market, source:MarketWatch, summary: Shares of DexCom Inc. slipped 0.50% to $115.70 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index...",DXCM
160,2023-04-16,"Headline: Notable Monday Option Activity: DXCM, TWLO, WIX, source:Stock Options Channel, summary: No summary",DXCM
161,2023-04-17,"Headline: DexCom upgraded to Strong Buy from Outperform at Raymond James, source:Thefly.com, summary: No summary, Headline: DexCom commends expansion of CGM Medicare to diabetics using all insulin types, source:Thefly.com, summary: No summary, Headline: DexCom price target raised to $132 from $126 at BTIG, source:Thefly.com, summary: No summary, Headline: DexCom raised, AngioDynamics cut as RayJay reviews post-COVID MedTech, source:Seeking Alpha, summary: No summary, Headline: Dexcom Commends Decision to Expand CGM Medicare Coverage to Include People With Diabetes Using All Types of Insulin, source:Yahoo, summary: SAN DIEGO, April 17, 2023--Dexcom Commends Decision to Expand CGM Medicare Coverage to Include People with Diabetes Using All Types of Insulin, Headline: DexCom Inc. stock rises Monday, outperforms market, source:MarketWatch, summary: Shares of DexCom Inc. advanced 2.55% to $118.65 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500..., Headline: Dexcom, A Top 3% Stock, Nears A Breakout On A 'Landmark' Medicare Win, source:Yahoo, summary: Dexcom stock closed in on a breakout Monday after Medicare officials announced the biggest-ever expansion for coverage of CGMs in the U.S.",DXCM
162,2023-04-18,"Headline: Raymond James Upgrades DexCom (DXCM), source:Fintel, summary: nan, Headline: BTIG Maintains DexCom (DXCM) Buy Recommendation, source:Fintel, summary: nan, Headline: Abbott Laboratories: Why I Am Fearful Ahead Of Q1 Earnings, source:SeekingAlpha, summary: nan, Headline: DexCom Inc. stock rises Tuesday, outperforms market, source:MarketWatch, summary: Shares of DexCom Inc. inched 0.24% higher to $118.93 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500...",DXCM
163,2023-04-19,"Headline: Are Medical Stocks Lagging  DexCom (DXCM) This Year?, source:Yahoo, summary: Here is how DexCom (DXCM) and Lantheus Holdings (LNTH) have performed compared to their sector so far this year., Headline: DexCom Inc. stock rises Wednesday, outperforms market, source:MarketWatch, summary: Shares of DexCom Inc. rose 4.36% to $124.12 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index...",DXCM
164,2023-04-20,"Headline: There's Been No Shortage Of Growth Recently For DexCom's (NASDAQ:DXCM) Returns On Capital, source:Yahoo, summary: If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Ideally, a..., Headline: DexCom Inc. stock falls Thursday, underperforms market, source:MarketWatch, summary: Shares of DexCom Inc. slid 1.55% to $122.19 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index..., Headline: Elliott Wave Technical Analysis: DexCom Inc, source:TalkMarkets, summary: No summary, Headline: DexCom Inc. stock rises Friday, outperforms market, source:MarketWatch, summary: No summary",DXCM
165,2023-04-21,"Headline: ClearBridge Large Cap Growth ESG Strategy Q1 2023 Portfolio Manager Commentary, source:SeekingAlpha, summary: nan",DXCM
166,2023-04-23,"Headline: DexCom Inc. stock rises Monday, still underperforms market, source:MarketWatch, summary: No summary",DXCM
167,2023-04-24,"Headline: DexCom (DXCM) to Report Q1 Earnings: What's in the Cards?, source:Yahoo, summary: DexCom's (DXCM) first-quarter results likely to reflect rising volumes across all channels.",DXCM
168,2023-04-25,"Headline: 2 Monster Stocks to Buy Without Any Hesitation, source:Yahoo, summary: Eli Lilly (NYSE: LLY) and DexCom (NASDAQ: DXCM) have characteristics in common that, in my view, make them monster stocks to buy without hesitation.  Both companies also have major tailwinds that should help drive revenue for years.  For DexCom, profits will be driven by the trend toward greater numbers of diabetes patients and their need for continuous glucose monitoring devices (CGMs)., Headline: DexCom Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: Shares of DexCom Inc. inched 0.10% higher to $123.96 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P...",DXCM
169,2023-04-26,"Headline: ���Sell In May Effect���: Uncovering Investment Opportunities During Seasonal Weakness, source:TalkMarkets, summary: No summary, Headline: Medical Device Stocks' Q1 Earnings on Apr 27: WST, DXCM, BAX, source:Yahoo, summary: Medical Device companies' Q1 results are likely to reflect strength in customer demand. Let's see how WST, DXCM and BAX are placed ahead of their earnings releases., Headline: DexCom Inc. stock rises Wednesday, outperforms market, source:MarketWatch, summary: Shares of DexCom Inc. inched 0.78% higher to $124.93 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the S&P..., Headline: GLOBAL BRIEFING: Samsung posts weakest profit in 14 years in Q1, source:Alliance News, summary: No summary, Headline: Notable companies reporting after market close, source:Thefly.com, summary: No summary, Headline: DexCom reports Q1 EPS 17c, consensus 15c, source:Thefly.com, summary: No summary, Headline: DexCom Non-GAAP EPS of $0.17 beats by $0.02, revenue of $741.5M beats by $20.98M, source:Seeking Alpha, summary: No summary, Headline: DexCom sees FY23 revenue $3.40B-$3.52B, consensus $3.47B, source:Thefly.com, summary: No summary",DXCM
170,2023-04-27,"Headline: DexCom raises outlook on Q1 beat and Medicare coverage, source:Seeking Alpha, summary: No summary, Headline: Fly Intel: After-Hours Movers, source:Thefly.com, summary: No summary, Headline: BTIG Reaffirms Their Buy Rating on Dexcom (DXCM), source:TipRanks, summary: No summary, Headline: Dexcom G6 Real-Time CGM System Now Accessible to Any Eligible Client Managing Diabetes With Insulin Through NIHB, source:Yahoo, summary: BURNABY, British Columbia, April 27, 2023--Dexcom, Inc. (NASDAQ: DXCM), a global leader in real-time continuous glucose monitoring (rtCGM) for people with diabetes, applauds the progressive expansion of coverage for continuous glucose monitoring systems through the Non-Insured Health Benefits (NIHB) program. Following an announcement made earlier this year, this decision further broadens the coverage criteria, now enabling any client managing diabetes with insulin to access the standard of care., Headline: 2 Growth Stocks That Could Double in 5 Years, source:Yahoo, summary: As a group, growth stocks had a year to forget in 2022.  Let's consider why both healthcare stocks could double in the next five years -- and for those keeping score at home, that amounts to a compound annual growth rate of almost 15%.  Vertex Pharmaceuticals is a biotech company best known for its lineup of medicines that treat the underlying causes of cystic fibrosis (CF), a rare genetic disease., Headline: DexCom: Q1 Earnings Snapshot, source:Associated Press, The, summary: No summary, Headline: DexCom quarterly profit halves, revenue up; expects growth full-year, source:Alliance News, summary: No summary, Headline: Dexcom Reports First Quarter 2023 Financial Results, source:Yahoo, summary: SAN DIEGO, April 27, 2023--Dexcom Reports First Quarter 2023 Financial Results, Headline: Dexcom, Inc. (DXCM) Q1 2023 Earnings Call Transcript, source:SeekingAlpha, summary: Dexcom, Inc. (NASDAQ:NASDAQ:DXCM) Q1 2023 Earnings Conference Call April 27, 2023 4:30 PM ETCompany ParticipantsSean Christensen - Director, Corporate Affairs & Head of IRKevin Sayer -..., Headline: DexCom (DXCM) Q1 Earnings and Revenues Beat Estimates, source:Yahoo, summary: DexCom (DXCM) delivered earnings and revenue surprises of 13.33% and 3.01%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?, Headline: Dexcom's Sales Growth Is Slowing, And The Top 2% Stock Just Skidded, source:Yahoo, summary: Dexcom lagged the most bullish expectations for its adjusted earnings late Thursday, but otherwise beat. Still, Dexcom stock skidded., Headline: Dow Jones Futures: Amazon Continues Earnings Surge For Tech Titans, But Cloudflare, Snap Plunge, source:Yahoo, summary: Amazon jumped late after Meta and Microsoft surged on earnings. But Cloudflare and Snap were the latest to plunge. Megacaps led Thursday's market rally but the gains were broad-based., Headline: Dexcom (DXCM) Gets a Buy from Bernstein, source:TipRanks, summary: No summary",DXCM
171,2023-04-28,"Headline: DexCom price target raised to $140 from $138 at Raymond James, source:Thefly.com, summary: No summary, Headline: Bank of America Securities Reaffirms Their Buy Rating on Dexcom (DXCM), source:TipRanks, summary: No summary, Headline: Dexcom (DXCM) Gets a Buy from Raymond James, source:TipRanks, summary: No summary, Headline: DexCom price target raised to $135 from $125 at Canaccord, source:Thefly.com, summary: No summary, Headline: Analysts` Top Healthcare Picks: Amgen (AMGN), Dexcom (DXCM), source:TipRanks, summary: No summary, Headline: DexCom selloff a buying opportunity, says Piper Sandler, source:Thefly.com, summary: No summary, Headline: Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Dexcom (DXCM) and Merck & Company (MRK), source:TipRanks, summary: No summary, Headline: DexCom price target raised to $134 from $132 at BTIG, source:Thefly.com, summary: No summary, Headline: DexCom price target raised to $150 from $142 at UBS, source:Thefly.com, summary: No summary, Headline: DexCom price target raised to $140 from $130 at Stifel, source:Thefly.com, summary: No summary, Headline: Dow Jones Futures Fall: Amazon Warns Of Slowing Cloud Growth; Cloudflare, Snap Plunge, source:Yahoo, summary: Amazon reversed lower late slowing on cloud computing growth. Cloudflare and Snap are the latest huge earnings losers. Megacaps led Thursday's market rally but the gains were broad-based., Headline: DexCom Q1 Earnings Beat Sets Stage For Upcoming Catalysts During 2023, Analyst Says, source:Yahoo, summary: DexCom Inc (NASDAQ: DXCM) raised its 2023 financial guidance following strong Q1 FY23 financial results. It posted Q1 sales of $741.50 million, up 18% Y/Y (19% organic basis), beating the consensus of $720.74 million. Volume growth, in conjunction with strong new customer additions, continues to be the primary driver of revenue growth. Highlights in the quarter included the U.S. launch of the next-generation Dexcom G7 CGM, initiated with a Super Bowl commercial. The company also finalized covera, Headline: DexCom (DXCM) Q1 Earnings Beat Estimates, Volumes Remain Strong, source:Yahoo, summary: DexCom's (DXCM) first-quarter 2023 results reflect strong domestic and international revenue growth on the back of its real-time Continuous Glucose Monitoring system., Headline: Raymond James Maintains Dexcom (DXCM) Strong Buy Recommendation, source:Fintel, summary: nan, Headline: Canaccord Genuity Maintains Dexcom (DXCM) Buy Recommendation, source:Fintel, summary: nan, Headline: DexCom Inc. stock underperforms Friday when compared to competitors, source:MarketWatch, summary: Shares of DexCom Inc. slipped 1.81% to $121.34 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500..., Headline: DexCom (DXCM) Q1 2023 Earnings Call Transcript, source:Yahoo, summary: Thank you, Abby, and welcome to DexCom's first-quarter 2023 earnings call.  Please note that there are also slides available related to our first-quarter performance on the DexCom's investor relations website on the events and presentations page., Headline: Stifel Maintains Dexcom (DXCM) Buy Recommendation, source:Fintel, summary: nan, Headline: BTIG Maintains Dexcom (DXCM) Buy Recommendation, source:Fintel, summary: nan",DXCM
172,2023-04-29,"Headline: Amazon Leads 5 S&P 500 Stocks Near Buy Points After Earnings, source:Yahoo, summary: Amazon is among S&P 500 stocks holding near buy points after surviving some volatility around earnings, removing a key risk.",DXCM
173,2023-05-01,"Headline: DexCom price target raised to $115 from $110 at Barclays, source:Thefly.com, summary: No summary, Headline: Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK) and Dexcom (DXCM), source:TipRanks, summary: No summary, Headline: Elliott Wave Technical Analysis: DexCom Inc, Monday, May 1, source:TalkMarkets, summary: No summary, Headline: Elliott Wave Technical Analysis: DexCom Inc, May 1, source:TalkMarkets, summary: No summary, Headline: DexCom Inc. stock falls Monday, underperforms market, source:MarketWatch, summary: Shares of DexCom Inc. shed 2.39% to $118.44 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index..., Headline: Barclays Maintains Dexcom (DXCM) Equal-Weight Recommendation, source:Fintel, summary: nan",DXCM
174,2023-05-02,"Headline: DexCom offers to sell $1.0B in convertible senior notes due 2028, source:Thefly.com, summary: No summary, Headline: DexCom proposes $1B notes offering, source:Seeking Alpha, summary: No summary, Headline: Wall Street Analysts Are Bullish on Top Healthcare Picks, source:TipRanks, summary: No summary, Headline: Is Dexcom a Good Stock to Buy Now?, source:Yahoo, summary: A poorly received first-quarter earnings report has investors wondering if this stock's best days are behind it., Headline: DexCom Takes Over #24 Spot From Mastercard, source:ETF Channel, summary: No summary, Headline: Dexcom Announces Proposed Offering of $1.0 Billion of Convertible Senior Notes, source:Yahoo, summary: SAN DIEGO, May 02, 2023--Dexcom Announces Proposed Offering of $1.0 Billion of Convertible Senior Notes, Headline: Video: S&P 500 Analyst Moves: DXCM, source:Market News Video, summary: No summary, Headline: DexCom Inc. stock falls Tuesday, still outperforms market, source:MarketWatch, summary: Shares of DexCom Inc. slumped 0.27% to $118.12 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index..., Headline: Baron Opportunity Fund Q1 2023 Shareholder Letter, source:SeekingAlpha, summary: Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing.",DXCM
175,2023-05-03,"Headline: DexCom prices upsized convertible senior note offering of $1.1B, source:Thefly.com, summary: No summary, Headline: DexCom prices $1.1B senior notes, source:Seeking Alpha, summary: No summary, Headline: Dexcom rtCGM is Likely to be Cost-Saving, Study Suggests, source:Yahoo, summary: EDINBURGH, Scotland, May 03, 2023--Dexcom rtCGM is associated with significant improvements over patients’ lifetimes and is likely to be cost-saving to the NHS, Headline: Dexcom Prices Upsized Offering of $1.1 Billion of 0.375% Convertible Senior Notes Due 2028, source:Yahoo, summary: SAN DIEGO, May 03, 2023--Dexcom Prices Upsized Offering of $1.1 Billion of 0.375% Convertible Senior Notes Due 2028, Headline: DexCom Inc. stock outperforms market despite losses on the day, source:MarketWatch, summary: Shares of DexCom Inc. slipped 0.68% to $117.32 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500...",DXCM
176,2023-05-04,"Headline: Tracking Baillie Gifford`s 13F Portfolio - Q1 2023 Update, source:Seeking Alpha, summary: No summary, Headline: Baron Health Care Fund Q1 2023 Shareholder Letter, source:SeekingAlpha, summary: Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing., Headline: 3 HealthTech Stocks to Watch as Digital Health Transforms the Industry, source:Yahoo, summary: Increasingly, technologies other than drugs are working to improve patient health. From diagnostic systems like MRIs and CAT scans to high-tech glucose monitoring systems to devices that destroy tumors, medicine makes use of many such technologies. Companies that develop technologies for the healthcare sector are referred to as healthtech companies. In this column, I will provide information about three of the best healthtech stocks available, focusing on companies that have developed non-drug t, Headline: DexCom Inc. stock rises Thursday, outperforms market, source:MarketWatch, summary: Shares of DexCom Inc. inched 0.09% higher to $117.42 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500..., Headline: Tracking Baillie Gifford's 13F Portfolio - Q1 2023 Update, source:SeekingAlpha, summary: Baillie Giffordâs 13F portfolio value increased from ~$96B to ~$111B this quarter. Click here to see an update on the portfolio for Q1 2023.",DXCM
177,2023-05-05,"Headline: DexCom participates in a conference call with JPMorgan, source:Thefly.com, summary: No summary, Headline: DexCom Inc. stock rises Friday, outperforms market, source:MarketWatch, summary: Shares of DexCom Inc. rose 2.90% to $120.82 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index...",DXCM
178,2023-05-08,"Headline: DexCom Inc. stock falls Monday, underperforms market, source:MarketWatch, summary: Shares of DexCom Inc. slid 0.53% to $120.18 Monday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index...",DXCM
179,2023-05-09,"Headline: DexCom Inc. stock outperforms market despite losses on the day, source:MarketWatch, summary: Shares of DexCom Inc. slumped 0.44% to $119.65 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index...",DXCM
180,2023-05-10,"Headline: What Makes DexCom (DXCM) an Attractive Investment?, source:Yahoo, summary: Baron Funds, an investment management company, released its “Baron Opportunity Fund” first quarter 2023 investor letter. A copy of the same can be downloaded here. In the first quarter, the fund outperformed the broader market and increased by 17.96% (Institutional Shares) compared to a 13.85% return for the Russell 3000 Growth Index and a 7.50% return […], Headline: DexCom Inc. stock rises Wednesday, outperforms market, source:MarketWatch, summary: Shares of DexCom Inc. advanced 2.44% to $122.57 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500..., Headline: Dexcom Showcases Accuracy, Reliability and Ease of Use of Its Dexcom G6 CGM System at the 66th Annual Meeting of the Japan Diabetes Society, source:Yahoo, summary: KAGOSHIMA, Japan, May 10, 2023--DexCom, Inc. (NASDAQ: DXCM), a global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, will showcase the accuracy, reliability and ease of use of its Dexcom G6 CGM System and will highlight the latest clinical evidence that continues to demonstrate the effectiveness of Dexcom CGM during the 66th Annual Meeting of the Japan Diabetes Society held May 11-13, 2023 in Kagoshima, Japan.",DXCM
181,2023-05-11,"Headline: DexCom Inc. stock underperforms Thursday when compared to competitors, source:MarketWatch, summary: Shares of DexCom Inc. slipped 1.22% to $121.07 Thursday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index..., Headline: Dexcom Shows Strength As Glucose Monitor Attracts Buyers, source:Yahoo, summary: Dexcom stock rebounds as glucose monitor maker sees expanding market. The med tech raised revenue guidance in its Q1 earnings report.",DXCM
182,2023-05-12,"Headline: DexCom Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: Shares of DexCom Inc. inched 0.52% higher to $121.70 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500...",DXCM
183,2023-05-13,"Headline: S&P 500 Medtech Play DexCom Leads Five Stocks Near Buy Points, source:Yahoo, summary: S&P 500 stock DexCom along with New Relic, Flywire, ASML and Kinsale Capital are in focus this week.  Leading the group is the S&P 500 medical technology stock DexCom.  Meanwhile, the Dow Jones Industrial Average along with the S&P 500 and other major stock indexes were down modestly Friday.",DXCM
184,2023-05-14,"Headline: Why Medtronic Could Have 25% Upside From Today`s Levels, source:Seeking Alpha, summary: No summary, Headline: Why Medtronic Could Have 25% Upside From Today's Levels, source:SeekingAlpha, summary: Medtronic has faced hurdles of its own making over the last three years, but its pipeline delivered some wins recently. Read why MDT stock is a Buy.",DXCM
185,2023-05-15,"Headline: 3 Stocks on the Verge of Breaking Out, source:Yahoo, summary: Andrew Rocco combines fundamentals and technicals to bring you 3 top stocks on the verge of breaking out., Headline: DexCom Inc. stock falls Monday, underperforms market, source:MarketWatch, summary: Shares of DexCom Inc. slipped 1.72% to $119.61 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...",DXCM
186,2023-05-16,"Headline: Zacks Investment Ideas feature highlights: Dexcom, Rambus, Advanced Micro Devices, Nvidia and Vipshops, source:Yahoo, summary: Dexcom, Rambus, Advanced Micro Devices, Nvidia and Vipshops are part of the Zacks Investment Ideas article., Headline: DexCom Inc. stock falls Tuesday, underperforms market, source:MarketWatch, summary: Shares of DexCom Inc. shed 0.84% to $118.61 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index..., Headline: DexCom Inc. stock outperforms competitors despite losses on the day, source:MarketWatch, summary: No summary",DXCM
187,2023-05-17,"Headline: Applied Materials, Lowe`s added to Jefferies franchise picks list, source:Seeking Alpha, summary: No summary, Headline: What Recession? These Companies Expect 20% Sales Growth This Year., source:Yahoo, summary: Recession or not, don't expect these businesses to run out of growth opportunities anytime soon., Headline: DexCom Inc. stock rises Thursday, still underperforms market, source:MarketWatch, summary: No summary",DXCM
188,2023-05-18,"Headline: DexCom Inc. stock underperforms Friday when compared to competitors, source:MarketWatch, summary: No summary",DXCM
189,2023-05-21,"Headline: These stock pickers led the health-fund category over the past 5 years. Here’s where they’re investing now., source:MarketWatch, summary: No summary, Headline: DexCom Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: No summary",DXCM
190,2023-05-22,"Headline: DexCom management to meet virtually with BTIG, source:Thefly.com, summary: No summary, Headline: 10 Health Care Stocks Whale Activity In Today's Session, source:Benzinga, summary: No summary, Headline: Billionaire Ken Griffin’s 2023 Portfolio: Top 15 Stock Picks, source:Yahoo, summary: In this piece, we will take a look at the top fifteen stocks in billionaire Ken Griffin’s 2023 portfolio. For more stocks, head on over to Billionaire Ken Griffin’s 2023 Portfolio: Top 5 Stock Picks. The stock market crash of 2022 hammered several major hedge funds. One of the biggest funds that bled capital last […], Headline: Noteworthy Tuesday Option Activity: DXCM, LMND, PINS, source:Stock Options Channel, summary: No summary, Headline: DexCom Inc. stock falls Tuesday, underperforms market, source:MarketWatch, summary: No summary",DXCM
191,2023-05-23,"Headline: Elliott Wave Technical Analysis: DexCom Inc. - Tuesday, May 23, source:TalkMarkets, summary: No summary, Headline: 10 Health Care Stocks Whale Activity In Today's Session, source:Benzinga, summary: No summary, Headline: Investing $1,000 in These 2 Top Growth Stocks Would Be a Brilliant Move, source:Yahoo, summary: Given the market volatility over the past few years, some investors are questioning whether they should still be putting their hard-earned money into the stock market.  Let's take a closer look at two excellent growth stocks to buy right now: Teladoc Health (NYSE: TDOC) and DexCom (NASDAQ: DXCM).  Last year was a horror show for Teladoc., Headline: DexCom Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: No summary",DXCM
192,2023-05-24,"Headline: DexCom: Growth Should Accelerate From Here, source:SeekingAlpha, summary: DexCom has shown positive performance and growth prospects in 1Q23. Check out why I reiterate my buy rating on DXCM stock., Headline: Insider Sell: EVP CFO Jereme Sylvain Sells 2,400 Shares of DexCom Inc (DXCM), source:GuruFocus, summary: No summary, Headline: 4 Growth Stocks to Buy and Hold Forever, source:Yahoo, summary: Some products and services are bigger than any economic, cultural, technological, or societal cycle., Headline: DexCom Unusual Options Activity, source:Benzinga, summary: No summary, Headline: DexCom Inc. stock outperforms competitors despite losses on the day, source:MarketWatch, summary: No summary",DXCM
193,2023-05-25,"Headline: DexCom: 120 Times Free Cash Flow Is Still Unreasonable, source:Seeking Alpha, summary: No summary, Headline: The Best Stocks to Invest $500 in Right Now, source:Yahoo, summary: While some investors may be discouraged by the market volatility that has continued from last year into 2023, the fact remains that truly great businesses are still growing even in an ongoing economic maelstrom.  While a full-fledged recession has the ability to hamper growth across a range of businesses and sectors, when you're looking at a multi-year buy-and-hold horizon for any stock you own, even these periods can be a short window against your overall investment period.  DexCom (NASDAQ: DXCM) has built a name for itself as a leader in diabetes care, a highly fragmented space with increasing levels of competition., Headline: 3 Reasons to Hold DexCom (DXCM) Stock in Your Portfolio, source:Yahoo, summary: Investors continue to be optimistic about DexCom (DXCM), owing to its strong product portfolio.",DXCM
194,2023-05-26,"Headline: The rise of continuous glucose monitors, source:CNBC, summary: According to the Center for Disease Control and Prevention, more than 37 million people in the U.S. have diabetes. Diabetics must monitor their blood sugar, a task traditionally done with glucometers by pricking your finger over and over again for drops of blood. But over the last decade, technology like continuous glucose monitoring has been on the rise. Abbott and Dexcom are the two most dominant players in the space. CNBC spoke with both companies about the technology inside CGM's., Headline: How Dexcom and Abbott are moving beyond diabetes with blood sugar monitoring, source:CNBC, summary: CNBC spoke with both Abbott and Dexcom about the technology inside continuous glucose monitors and how they see the technology expanding., Headline: DexCom Inc. stock rises Friday, still underperforms market, source:MarketWatch, summary: Shares of DexCom Inc. inched 0.38% higher to $115.05 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P...",DXCM
195,2023-05-29,"Headline: LLY, DXCM, or ISRG: Which Healthcare Stock is the Most Attractive Pick?, source:TipRanks, summary: No summary, Headline: LLY, DXCM, or ISRG: Which Healthcare Stock is the Top Stock Pick?, source:TipRanks, summary: No summary, Headline: DexCom management to meet virtually with BTIG, source:Thefly.com, summary: No summary",DXCM
196,2023-05-30,"Headline: DexCom assumed with an Equal Weight at Morgan Stanley, source:Thefly.com, summary: No summary, Headline: Elliott Wave Technical Analysis: DexCom Inc. - Tuesday, May 30, source:TalkMarkets, summary: No summary, Headline: Where DexCom Stands With Analysts, source:Benzinga, summary: No summary, Headline: DexCom Inc. stock falls Tuesday, underperforms market, source:MarketWatch, summary: Shares of DexCom Inc. slid 1.30% to $113.56 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index...",DXCM
197,2023-05-31,"Headline: 3 Stock-Split Stocks Billionaires Can't Stop Buying, source:Yahoo, summary: Based on the latest round of 13F filings, a number of prominent billionaire investors piled into three fast-growing stock-split stocks., Headline: 2 Incredible Growth Stocks to Buy Before the Next Bull Market, source:Yahoo, summary: These companies have what it takes to keep growing and enriching investors in the years ahead.",DXCM
198,2023-06-01,"Headline: Analysts Are Bullish on Top Healthcare Stocks: Dr Reddy’s Laboratories (RDY), Dexcom (DXCM), source:TipRanks, summary: No summary, Headline: Dexcom Announces Upcoming Conference Presentation, source:Yahoo, summary: SAN DIEGO, June 01, 2023--DexCom, Inc. (NASDAQ:DXCM) today announced that Jereme Sylvain, Executive Vice President and Chief Financial Officer, will present an update on the company at William Blair's 43rd Annual Growth Stock Conference on Wednesday, June 7th., Headline: 15 Best Healthcare Stocks To Buy Now, source:Yahoo, summary: In this article, we will take a look at the 15 best healthcare stocks to buy now. For more stocks, head on over to 5 Best Healthcare Stocks To Buy Now. In the midst of uncertain economic conditions globally, the healthcare sector has displayed a notable degree of resilience. Historically, the demand for healthcare products […], Headline: DexCom Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: Shares of DexCom Inc. advanced 1.98% to $119.58 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...",DXCM
199,2023-06-02,"Headline: Senseonics spikes on UnitedHealthcare coverage for glucose monitoring device, source:Seeking Alpha, summary: No summary, Headline: DexCom Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: Shares of DexCom Inc. rose 2.50% to $122.57 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index..., Headline: Stock Market Rally Shows Character Change With Tesla, Apple In Focus; Here's What To Do Now, source:Yahoo, summary: The market rally is stepping up with broad gains. Tesla broke out while Apple has a big product reveal. Here's what you should do now.",DXCM
200,2023-06-03,"Headline: Want $1 Million in Retirement? Invest $250,000 in These 3 Stocks and Wait a Decade, source:Yahoo, summary: Let's consider three stocks that could: Vertex Pharmaceuticals (NASDAQ: VRTX), DexCom (NASDAQ: DXCM), and Amazon (NASDAQ: AMZN).  Vertex Pharmaceuticals is doing great things.  One of the drugmakers that was closest to entering this market with competing products recently threw in the towel., Headline: S&P 500 Giant Tesla Leads Five Stocks Near Buy Points As Market Revs Up, source:Yahoo, summary: The EV giant broke out this week, leading a group of stocks around buy points as the market rally attempts to gather steam., Headline: Stock Market Rally Makes Bullish Character Change With Tesla, Apple In Focus; Here's What To Do Now, source:Yahoo, summary: The market rally is stepping up with broad gains. Tesla broke out while Apple has a big product reveal. Here's what you should do now.",DXCM
201,2023-06-04,"Headline: 10 Internet of Things (IoT) Stocks Billionaires Are Loading Up On, source:Yahoo, summary: In this piece, we will take a look at the ten internet of things (IoT) stocks billionaires are loading on. For more IoT stocks, head on over to 5 Internet of Things (IoT) Stocks Billionaires Are Loading Up On. As a technology, the consumer use of the Internet is entering its fourth decade. And over […], Headline: Dow Jones Futures: Character Change For Market; Oil Prices Pop On Saudi Output Cut, source:Yahoo, summary: The market sent bullish signals last week. Crude prices jumped as Saudi Arabia cut output. Apple and Palo Alto have big news. Tesla is in a buy zone., Headline: If You Invested $100 In This Stock 15 Years Ago, You Would Have $6,800 Today, source:Benzinga, summary: No summary",DXCM
202,2023-06-05,"Headline: Early notable gainers among liquid option names on June 5th, source:Thefly.com, summary: No summary, Headline: DexCom Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: Shares of DexCom Inc. rallied 1.71% to $124.66 Monday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index..., Headline: Dow Jones Falls As Apple Unveils These Products; This Stock Soars After Cathie Wood Sells It, source:Yahoo, summary: The Dow Jones slid while Apple stock reversed despite unveiling the Vision Pro headset. A Cathie Wood stock popped higher., Headline: Market Rally Retreats On Apple Reveal, But Not Much; 5 Stocks In Buy Areas, source:Yahoo, summary: The market rally saw modest losses Monday as Apple dipped after unveiling its $3,499 Vision Pro goggles. Tesla leads five stocks in buy areas., Headline: Frank Sands' Top 1st-Quarter Buys, source:GuruFocus, summary: No summary, Headline: DexCom Now #152 Largest Company, Surpassing Roper Technologies, source:The Online Investor, summary: No summary",DXCM
203,2023-06-06,"Headline: Have $1,500? 2 Top Growth Stocks to Buy and Hold for the Long Haul, source:Yahoo, summary: In a time where recession concerns remain for many investors, and the market is continuing to deal with regular bouts of volatility, it can be easy to lose sight of your long-term investment horizon and get caught up in the day-to-day machinations of the market.  If you're looking for two compelling businesses to invest $1,500 in this month, here are two names to consider hitting the buy button on right now.  Fiverr (NYSE: FVRR) continues to help customers, from small enterprises to massive brands, connect with freelancers that meet their business needs., Headline: Dow Jones Futures Fall: Market Rally Retreats On Apple; 5 Stocks In Buy Areas, source:Yahoo, summary: The market rally saw modest losses Monday as Apple dipped after unveiling its $3,499 Vision Pro goggles. Tesla leads five stocks in buy areas., Headline: 10 Top-Rated Stocks Billionaires Are Loading Up On, source:Yahoo, summary: In this piece, we will take a look at the ten top rated stocks billionaires are loading up on. For more stocks, head on over to 5 Top-Rated Stocks Billionaires Are Loading Up On. The U.S. economy has undergone several shocks over the past couple of years. This turmoil started after the onset of the […], Headline: DexCom Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: Shares of DexCom Inc. inched 0.58% higher to $125.38 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P..., Headline: Dow Jones Giant McDonald's Tests Key Support Level; Tesla Stock In Buy Range, source:Yahoo, summary: Dow Jones leader McDonald's is trying to find support around a key level, while Tesla stock is in buy range past its latest entry.",DXCM
204,2023-06-07,"Headline: SPY ETF Gains 13% YTD; Analysts See Further Upside, source:TipRanks, summary: No summary, Headline: DexCom Inc. stock falls Wednesday, underperforms market, source:MarketWatch, summary: Shares of DexCom Inc. shed 4.52% to $119.71 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...",DXCM
205,2023-06-08,"Headline: Here’s Why the QQQ ETF Could Be a Great Pick, source:TipRanks, summary: No summary, Headline: Elliott Wave Technical Analysis: DexCom Inc. - Thursday, June 8, source:TalkMarkets, summary: No summary, Headline: Dexcom to Host Investor Day on June 23, 2023, source:Yahoo, summary: SAN DIEGO, June 08, 2023--DexCom, Inc. (NASDAQ:DXCM) today announced that it will host an Investor Day on June 23rd from 2:30 PM until approximately 5:00 PM PST (5:30 PM – 8:00 PM EST). The event will include presentations from Dexcom management highlighting the company’s market opportunities, business strategy, innovation efforts, and long-term financial outlook., Headline: Dow Jones Rises After Surprise Jump In Jobless Claims; GME Stock Crashes 22% After Firing CEO, source:Yahoo, summary: The Dow Jones rose Thursday on a surprise jump in weekly jobless claims. GME stock crashed after the company fired its chief executive., Headline: DexCom Inc. stock rises Thursday, outperforms market, source:MarketWatch, summary: Shares of DexCom Inc. rallied 1.19% to $121.13 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500..., Headline: 15 Healthcare Stocks Billionaires Are Loading Up On, source:Yahoo, summary: In this article, we discuss 15 best healthcare stocks billionaires are loading up on. You can skip our detailed discussion on the healthcare sector and its performance, and go directly to read 5 Healthcare Stocks Billionaires Are Loading Up On. The healthcare sector in the US is a multifaceted industry that plays a crucial role […]",DXCM
206,2023-06-09,"Headline: Why Is Steris (STE) Down 0.9% Since Last Earnings Report?, source:Yahoo, summary: Steris (STE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues., Headline: DexCom Inc. stock rises Friday, outperforms market, source:MarketWatch, summary: Shares of DexCom Inc. rose 2.65% to $124.34 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...",DXCM
207,2023-06-12,"Headline: New Study Shows That 84% of People With Diabetes Struggle With Mental Health¹, source:Business Wire, summary: No summary, Headline: New Study Shows That 84% of People With Diabetes Struggle With Mental Health1, source:Yahoo, summary: LONDON, June 12, 2023--Dexcom to host uplifting Puppy Yoga Event in London with Roxy Horner and Henry Slade for Diabetes Awareness Week, Headline: Dow Jones Rises Ahead Of Inflation Data, Fed Meeting; AMD, Amazon Rally On Price-Target Hikes, source:Yahoo, summary: The Dow Jones rose Monday ahead of this week's inflation data and two-day Fed meeting. AMD and Amazon rallied on price-target hikes.",DXCM
208,2023-06-13,"Headline: Dow Jones Rallies On Cool CPI Inflation Data; Cathie Wood Sells $92 Million Of Tesla Stock, source:Yahoo, summary: The Dow Jones rose Tuesday on cooler-than-expected CPI inflation data. Cathie Wood's Ark Invest sold Tesla stock., Headline: DexCom Inc. stock falls Tuesday, underperforms market, source:MarketWatch, summary: Shares of DexCom Inc. slipped 0.76% to $125.95 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500..., Headline: Commit To Purchase DexCom At $110, Earn 8.8% Using Options, source:Stock Options Channel, summary: No summary",DXCM
209,2023-06-14,"Headline: Elliott Wave Technical Analysis: Dexcom Inc., Wednesday, June 14, source:TalkMarkets, summary: No summary, Headline: Dow Jones Falls After Key Inflation Data; Fed Decision, Powell Comments Later, source:Yahoo, summary: The Dow Jones fell Wednesday after key inflation data. The Fed's interest rate decision and Fed Chair Powell's comments are later today., Headline: DexCom Inc. stock underperforms Wednesday when compared to competitors despite daily gains, source:MarketWatch, summary: Shares of DexCom Inc. inched 0.88% higher to $127.06 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P...",DXCM
210,2023-06-15,"Headline: DexCom (NASDAQ:DXCM) shareholder returns have been incredible, earning 410% in 5 years, source:Yahoo, summary: Long term investing can be life changing when you buy and hold the truly great businesses. While not every stock..., Headline: Dow Jones Rallies After Surprise Rise In Jobless Claims; Tesla Stock Reverses Higher, source:Yahoo, summary: The Dow Jones rallied Thursday after a surprise rise in jobless claims. Tesla stock reversed higher after snapping a record win streak., Headline: Spotlight Shines On Super Bowl, Chip Stocks And Nick Jonas, source:Yahoo, summary: As diabetes leader Dexcom pumps up 113% growth and a collaboration with Nick Jonas, Dexcom stock pokes at a new buy zone., Headline: DexCom Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: Shares of DexCom Inc. advanced 3.09% to $130.98 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500..., Headline: Catalyst watch: Powell testifies to Congress, Microsoft-Activision Blizzard hearing and Dollar Tree event, source:Seeking Alpha, summary: No summary",DXCM
211,2023-06-16,"Headline: Dow Jones Rises Ahead Of Inflation Survey; Virgin Galactic Rockets 40% On Spaceflight Plans, source:Yahoo, summary: The Dow Jones rose Friday ahead of a key inflation survey. Virgin Galactic rocketed 40% on plans to launch its first spaceflight in June., Headline: Dow Jones Rises After Cool Inflation Survey; Virgin Galactic Rockets 40% On Spaceflight Plans, source:Yahoo, summary: The Dow Jones rose Friday after a cool inflation survey. Virgin Galactic rocketed on plans to launch its first spaceflight in June., Headline: As DexCom Breaks Out to the Upside, Further Gains Are Expected, source:Yahoo, summary: Medical device maker DexCom  has been climbing higher on the charts the past year.  Let's see what the indicators and price targets look like now.  The On-Balance-Volume (OBV) line dipped in May but has been climbing again in June., Headline: DexCom Inc. stock falls Friday, underperforms market, source:MarketWatch, summary: Shares of DexCom Inc. slipped 0.67% to $130.10 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index..., Headline: I would use any upcoming sell-off as a chance to get into the stock market, say Jim Cramer, source:CNBC, summary: 'Mad Money' host Jim Cramer breaks down the market's strong week and looks ahead to next week's big earnings reports.",DXCM
212,2023-06-20,"Headline: Elliott Wave Technical Analysis: DexCom Inc, June 20, source:TalkMarkets, summary: No summary, Headline: Dow Jones Falls 375 Points After Key Housing Data; Alibaba Slides As CEO Steps Down, source:Yahoo, summary: The Dow Jones Industrial Average dropped Tuesday after key housing data. Chinese e-commerce giant Alibaba slid after the CEO stepped down., Headline: DexCom Inc. stock underperforms Tuesday when compared to competitors, source:MarketWatch, summary: Shares of DexCom Inc. slid 0.10% to $129.97 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index..., Headline: If You Invested $1000 In This Stock 15 Years Ago, You Would Have $74,000 Today, source:Benzinga, summary: No summary, Headline: Here’s Why the Invesco QQQ Trust ETF is Worth Considering, source:TipRanks, summary: No summary",DXCM
213,2023-06-21,"Headline: Here’s Why the Invesco QQQ Trust ETF is Appealing, source:TipRanks, summary: No summary, Headline: Dexcom G6 Strengthens Its Position as World’s Most Connected CGM System, source:Yahoo, summary: LONDON, June 21, 2023--Dexcom G6 is now the first and only CGM to connect with the Omnipod® 5 Automated Insulin Delivery System in the United Kingdom, Headline: Dow Jones Falls 150 Points As Powell Expects More Rate Hikes; Tesla Stock Downgraded, source:Yahoo, summary: The Dow Jones fell Wednesday, as Fed Chair Jerome Powell expects more rate hikes to fight inflation. Tesla stock was downgraded at Barclays., Headline: DexCom Inc. stock falls Wednesday, underperforms market, source:MarketWatch, summary: Shares of DexCom Inc. slid 1.62% to $127.86 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...",DXCM
214,2023-06-22,"Headline: 3 Reasons to Hold DexCom (DXCM) Stock in Your Portfolio, source:Yahoo, summary: DexCom (DXCM) continues to raise optimism among investors, owing to its strong product portfolio., Headline: Dow Jones Falls After Jobless Claims; Powell Speech Now; Tesla Stock Downgraded, source:Yahoo, summary: The Dow Jones dropped Thursday morning after jobless claims ahead of Fed Chair Powell's speech. Tesla stock fell on another downgrade., Headline: DexCom Inc. stock falls Thursday, underperforms market, source:MarketWatch, summary: Shares of DexCom Inc. shed 1.05% to $126.52 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index...",DXCM
215,2023-06-23,"Headline: Goldman adds 25 new stocks with growth potential to its ROE basket, source:Seeking Alpha, summary: No summary, Headline: DexCom (DXCM) Stock Declined on Profit Taking, source:Yahoo, summary: The Ithaka Group, an investment advisory firm, released “Ithaka US Growth Strategy” first-quarter investor letter. A copy of the same can be downloaded here. In the quarter, the strategy returned 21.8% gross and 21.7% net compared to 14.4% for the Russell 1000 Growth Index. The outperformance of the fund was due to stock selection, with […], Headline: DexCom call volume above normal and directionally bullish, source:Thefly.com, summary: No summary, Headline: DexCom Unusual Options Activity, source:Benzinga, summary: No summary, Headline: DexCom Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: Shares of DexCom Inc. inched 0.18% higher to $126.75 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500..., Headline: Global Continuous Glucose Monitoring Pioneer Dexcom Reveals New Plans to Bring Sensing Technology to Millions More, source:Business Wire, summary: No summary, Headline: Dow Jones Futures: Market Pullback Healthy As Apple Hits Record High; What To Do Now, source:Yahoo, summary: The market pullback appears healthy so far as Apple, Nvidia and other giants hold strong. MongoDB leads stocks near buy points., Headline: Dexcom Updates Long-Range Financial Targets, source:Yahoo, summary: SAN DIEGO, June 24, 2023--Dexcom Updates Long-Range Financial Targets, Headline: Dexcom Updates Long-Range Financial Targets, source:Yahoo, summary: SAN DIEGO, June 24, 2023--Dexcom Updates Long-Range Financial Targets, Headline: Global Continuous Glucose Monitoring Pioneer Dexcom Reveals New Plans to Bring Sensing Technology to Millions More, source:Yahoo, summary: SAN DIEGO, June 24, 2023--Global Continuous Glucose Monitoring Pioneer Dexcom Reveals New Plans to Bring Sensing Technology to Millions More, Headline: Dexcom, A Top 2% Stock, Raises 2025 Outlook Amid 'Rapidly' Expanding Diabetes Market, source:Yahoo, summary: Dexcom's revenue could reach $5 billion in 2025, the company said Friday as it announced a new CGM device. Dexcom stock could soar again.",DXCM
216,2023-06-25,"Headline: DexCom raises FY25 revenue guidance to $4.6B-$5.1B from $4B-$4.5B, source:Thefly.com, summary: No summary, Headline: Dow Jones Futures Rise: Time To Buy These 5 Stocks Amid Market Pullback?, source:Yahoo, summary: Several stocks are near buy points, amid an orderly market pullback as Apple and other giants hold strong., Headline: DexCom raises 2025 financial targets after strong two years, source:Alliance News, summary: No summary, Headline: What You Missed On Wall Street On Monday, source:Thefly.com, summary: No summary",DXCM
217,2023-06-26,"Headline: Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Dexcom (DXCM) and Genmab (GMAB), source:TipRanks, summary: No summary, Headline: Dexcom (DXCM) Gets a Buy from Jefferies, source:TipRanks, summary: No summary, Headline: DexCom price target raised to $150 from $134 at BTIG, source:Thefly.com, summary: No summary, Headline: Dow Jones Futures Fall: Time To Buy These Stocks Amid Market Pullback? Tesla Downgraded Again, source:Yahoo, summary: Several stocks are near buy points, amid an orderly market pullback as Apple and other giants hold strong., Headline: DexCom Unusual Options Activity For June 26, source:Benzinga, summary: No summary, Headline: What You Missed On Wall Street This Morning, source:Thefly.com, summary: No summary, Headline: DexCom Revises 2025 Outlook, Announces New Product For Diabetics, source:Yahoo, summary: DexCom Inc (NASDAQ: DXCM) disclosed the 2025 financial targets revision at its investor day last week. The company raised the outlook for revenue to $4.6 billion - $5.1 billion (from $4.0 billion - $4.5 billion), adjusted operating profit margin to 21% (from 20%), and adjusted EBITDA margin to 31% (from 30%) for 2025. On the other hand, the company reiterated 2025 guidance for an adjusted gross margin of 65%. ""Dexcom continues to execute on our vision to drive better health outcomes throughout t, Headline: DexCom Inc. stock falls Monday, underperforms market, source:MarketWatch, summary: Shares of DexCom Inc. slid 1.68% to $124.62 Monday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index..., Headline: Dexcom, A Top 3% Stock, Raises 2025 Outlook Amid 'Rapidly' Expanding Diabetes Market, source:Yahoo, summary: Dexcom's revenue could reach $5 billion in 2025, the company said Friday as it announced a new CGM device. But Dexcom stock fell Monday., Headline: EVP Managing Director Steven Pacelli Sells 412 Shares of DexCom Inc (DXCM), source:GuruFocus, summary: No summary",DXCM
218,2023-06-27,"Headline: Dexcom (DXCM) to Launch New Product in 2024, Ups Long-Term View, source:Yahoo, summary: Dexcom (DXCM) announces encouraging developments in 2024, including faster coverage for its products by private payers and new product launch for diabetic patients not on insulin., Headline: DexCom Inc. stock falls Tuesday, underperforms market, source:MarketWatch, summary: Shares of DexCom Inc. slumped 0.90% to $123.50 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500..., Headline: BTIG Maintains Dexcom (DXCM) Buy Recommendation, source:Fintel, summary: nan",DXCM
219,2023-06-28,"Headline: Early notable gainers among liquid option names on June 28th, source:Thefly.com, summary: No summary, Headline: Here's How Much a $1000 Investment in DexCom Made 10 Years Ago Would Be Worth Today, source:Yahoo, summary: Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more., Headline: Looking for a Growth Stock? 3 Reasons Why DexCom (DXCM) is a Solid Choice, source:Yahoo, summary: DexCom (DXCM) could produce exceptional returns because of its solid growth attributes., Headline: Peering Into DexCom's Recent Short Interest, source:Benzinga, summary: No summary",DXCM
220,2023-06-29,"Headline: Elliott Wave Technical Analysis: DexCom Inc. - Thursday, June 29, source:TalkMarkets, summary: No summary, Headline: DexCom (DXCM) Just Flashed Golden Cross Signal: Do You Buy?, source:Yahoo, summary: Should investors be excited or worried when a stock crosses above the 20-day simple moving average?, Headline: DexCom Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: Shares of DexCom Inc. rose 1.20% to $127.94 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...",DXCM
221,2023-06-30,"Headline: Friday's ETF Winners And Losers: Large-Cap Fund Flows - VOO and SPY Add More Than $1.5 Billion Each, source:Benzinga, summary: No summary, Headline: DexCom Inc. stock rises Friday, still underperforms market, source:MarketWatch, summary: Shares of DexCom Inc. inched 0.45% higher to $128.51 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P...",DXCM
222,2023-07-03,"Headline: Goldman Sachs Reveals Winning Portfolio: 'Rule of 10' Unlocks S&P 500's Future Top Performers, source:Benzinga, summary: No summary, Headline: Netflix, Disney, Datadog among BofA's 10 best ideas for Q3, source:Seeking Alpha, summary: No summary",DXCM
223,2023-07-04,"Headline: DexCom says Health Canada approved Dexcom G7, source:Thefly.com, summary: No summary, Headline: Dexcom G7 Receives Health Canada Approval : Next-Generation Continuous Glucose Monitoring System With Unmatched Accuracy Coming to Canadians, source:Finnhub, summary: Dexcom G7 is the most accurate CGM system1 approved by Health Canada, building on the trusted performance of Dexcom CGM, which is clinically proven to lower A1C, reduce hypoglycemia, and improve time in range2,3,4.



Made with users in mind, Dexcom G7 combines simplicity and power, introducing a better way to manage diabetes2,3,4., Headline: DexCom's continuous glucose monitoring system gets Canadian approval, source:Alliance News, summary: No summary, Headline: Dexcom G7 Receives Health Canada Approval: Next-Generation Continuous Glucose Monitoring System With Unmatched Accuracy Coming to Canadians, source:Yahoo, summary: BURNABY, British Columbia, July 04, 2023--Dexcom, Inc. (NASDAQ: DXCM), a global leader in real-time continuous glucose monitoring (rtCGM) for people with diabetes, announced today that Health Canada has approved the next-generation Dexcom G7 Continuous Glucose Monitoring System for people with all types of diabetes, ages two years and older., Headline: GLOBAL BRIEFING: Growth in China's services sector slows in June, source:Alliance News, summary: No summary, Headline: A Look Into DexCom Inc's Price Over Earnings, source:Benzinga, summary: No summary",DXCM
224,2023-07-05,"Headline: Dexcom announces Health Canada approval for Dexcom G7, source:Thefly.com, summary: No summary, Headline: Dexcom G7 Continuous Glucose Monitoring System Gets Regulatory Nod From Health Canada, source:Benzinga, summary: No summary, Headline: DexCom's (DXCM) G7 CGM System Gets Nod From Health Canada, source:Yahoo, summary: DexCom's (DXCM) G7 CGM System's latest approval by Health Canada is expected to combine simplicity and power, thereby providing a better way to manage diabetes., Headline: DexCom Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: Shares of DexCom Inc. inched 0.83% higher to $128.07 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the S&P...",DXCM
225,2023-07-06,"Headline: Dexcom Schedules Second Quarter 2023 Earnings Release and Conference Call for July 27, 2023 at 4 : 30 p.m. Eastern Time, source:Finnhub, summary: DexCom, Inc.  today announced that it plans to release its second quarter 2023 financial results after market close on Thursday, July 27, 2023. Management will hold a conference call to review the..., Headline: Dexcom Schedules Second Quarter 2023 Earnings Release and Conference Call for July 27, 2023 at 4:30 p.m. Eastern Time, source:Yahoo, summary: SAN DIEGO, July 06, 2023--DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its second quarter 2023 financial results after market close on Thursday, July 27, 2023. Management will hold a conference call to review the company's second quarter 2023 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on the Dexcom investor relations website at investors.dexcom.com and will be, Headline: DexCom: Fantastic Growth But A High Premium To Pay Right Now, source:SeekingAlpha, summary: DexCom's share price has increased by 414% over the last five years. Read more to see why I rate DXCM stock a hold currently rather than a buy., Headline: 15 Best NASDAQ Stocks To Buy Today, source:Yahoo, summary: In this piece, we will take a look at 15 best NASDAQ stocks to buy today. If you want to skip our analysis of the stock market, market indexes, and recent developments, head on over to 5 Best NASDAQ Stocks To Buy Today. The U.S. economy finally appears to be stabilizing. Throughout 2023, worries of […], Headline: DexCom Inc. stock falls Thursday, still outperforms market, source:MarketWatch, summary: Shares of DexCom Inc. shed 0.29% to $127.70 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index..., Headline: Dow Jones Falls With Jobs Report Due; Meta's Threads Has Record Launch As Elon Musk Decries 'Cheating', source:Yahoo, summary: Stocks retreated as Treasury yields jumped on hot economic data ahead of Friday's jobs report. Meta's Threads had record first-day downloads as Elon Musk decried ""cheating."", Headline: Dow Jones Futures: Jobs Report On Tap; Threads Off To Record Start As Elon Musk Rips 'Cheating', source:Yahoo, summary: Stocks retreated as Treasury yields jumped on hot economic data ahead of Friday's jobs report. Meta's Threads had record first-day downloads as Elon Musk decried ""cheating."", Headline: Here's How Much You Would Have Made Owning DexCom Stock In The Last 5 Years, source:Benzinga, summary: No summary",DXCM
226,2023-07-07,"Headline: Dow Jones Futures Fall With Jobs Report Due; Meta Leads 7 Resilient Stocks, source:Yahoo, summary: The jobs report looms with Treasury yields soaring. Meta is among stocks holding up as Threads had record first-day downloads., Headline: 2 Growth Stocks That Could Double in 5 Years, source:Yahoo, summary: Turning an initial capital of, say, $1000 into double that in half a decade amounts to a compound annual growth rate of nearly 15%.  Let's look at two companies that appear able to accomplish this feat: DexCom (NASDAQ: DXCM) and Etsy (NASDAQ: ETSY).  DexCom is looking at a massive opportunity in the market for continuous glucose monitoring (CGM) systems., Headline: DexCom Inc. stock outperforms competitors despite losses on the day, source:MarketWatch, summary: Shares of DexCom Inc. dropped 0.78% to $126.71 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index...",DXCM
227,2023-07-08,"Headline: Nvidia And This AI Stock Lead 5 Names Near Buy Points, source:Yahoo, summary: Nvidia stock has soared this year, but the artificial intelligence play has traded in a super-tight range the past three weeks, creating a new buy point.",DXCM
228,2023-07-09,"Headline: Goldman Sachs sees rays of hope in underperforming health sector, source:Seeking Alpha, summary: No summary",DXCM
229,2023-07-10,"Headline: DexCom price target raised to $150 from $146 at Citi, source:Thefly.com, summary: No summary, Headline: DexCom Inc. stock rises Monday, outperforms market, source:MarketWatch, summary: Shares of DexCom Inc. rose 3.09% to $130.62 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index...",DXCM
230,2023-07-11,"Headline: Citigroup Maintains Dexcom (DXCM) Buy Recommendation, source:Fintel, summary: nan, Headline: DexCom Inc. stock rises Tuesday, still underperforms market, source:MarketWatch, summary: Shares of DexCom Inc. inched 0.47% higher to $131.23 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P...",DXCM
231,2023-07-12,"Headline: 10 Health Care Stocks With Whale Alerts In Today's Session, source:Benzinga, summary: No summary, Headline: DexCom Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: Shares of DexCom Inc. advanced 1.86% to $133.67 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P...",DXCM
232,2023-07-13,"Headline: AngioDynamics (ANGO) Q4 Earnings Lag Estimates, Revenues Top, source:Yahoo, summary: AngioDynamics (ANGO) registers strong revenue growth in the Med Tech and Med Device businesses in fourth-quarter fiscal 2023., Headline: DexCom Inc. stock rises Thursday, still underperforms market, source:MarketWatch, summary: Shares of DexCom Inc. inched 0.23% higher to $133.98 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the..., Headline: DexCom (DXCM) Gains But Lags Market: What You Should Know, source:Yahoo, summary: In the latest trading session, DexCom (DXCM) closed at $133.98, marking a +0.23% move from the previous day.",DXCM
233,2023-07-14,"Headline: DexCom (DXCM) Stock Hits 52-Week High: More Room to Grow?, source:Yahoo, summary: DexCom (DXCM) continues to raise optimism among investors, owing to its strong product portfolio., Headline: Here is Why Growth Investors Should Buy DexCom (DXCM) Now, source:Yahoo, summary: DexCom (DXCM) could produce exceptional returns because of its solid growth attributes., Headline: DexCom Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: Shares of DexCom Inc. rose 2.49% to $137.32 Friday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...",DXCM
234,2023-07-16,"Headline: DexCom Inc. stock rises Monday, still underperforms market, source:MarketWatch, summary: No summary",DXCM
235,2023-07-17,"Headline: DexCom Reaches Analyst Target Price, source:ETF Channel, summary: No summary, Headline: If You Invested $1000 in DexCom a Decade Ago, This is How Much It'd Be Worth Now, source:Yahoo, summary: Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards., Headline: DexCom Inc. stock rises Tuesday, still underperforms market, source:MarketWatch, summary: No summary",DXCM
236,2023-07-18,"Headline: DexCom Inc. stock falls Wednesday, underperforms market, source:MarketWatch, summary: No summary, Headline: Senseonics initiated with an Underperform at Jefferies, source:Thefly.com, summary: No summary",DXCM
237,2023-07-19,"Headline: Elliott Wave Technical Analysis: DexCom Inc. - Wednesday, July 19, source:TalkMarkets, summary: No summary, Headline: Senseonics begun at underperform at Jefferies on glucose monitoring market, source:Seeking Alpha, summary: No summary, Headline: DexCom Inc. stock falls Thursday, underperforms market, source:MarketWatch, summary: No summary",DXCM
238,2023-07-20,"Headline: Top Picks: 3 Stocks That (Almost) All Analysts Agree On, source:Yahoo, summary: Regarding the best stocks to buy, some investors look to analyst consensus stocks — companies that everyone on Wall Street fawns over. I did a quick Finviz.com screen of S&P 500 companies. The lowest rating from analysts — the lower, the better — was 1.50 for DexCom (NASDAQ:DXCM), a maker of glucose monitoring systems. The highest was a tie among four companies, each with a 3.50 rating. The top 20 companies (including those that tied) rated between 1.50 for DXCM and 1.80. Of the 36 at 1.80 or le, Headline: DexCom Inc. stock underperforms Friday when compared to competitors, source:MarketWatch, summary: No summary",DXCM
239,2023-07-21,"Headline: Invesco QQQ Trust ETF: What Lies Ahead?, source:TipRanks, summary: No summary, Headline: 3 Highly-Ranked Large Cap Stocks to Buy Before Earnings for Big Upside, source:Yahoo, summary: Exploring three highly-ranked large-cap stocks--Honeywell, DexCom, and NextEra Energy--that investors might want to buy before their upcoming earnings releases for both near-term and long-term upside., Headline: DexCom (DXCM) Stock Sinks As Market Gains: What You Should Know, source:Yahoo, summary: DexCom (DXCM) closed the most recent trading day at $130.60, moving -0.04% from the previous trading session.",DXCM
240,2023-07-23,"Headline: Good News: New Bull Market, Bad News: Growth Stocks Earnings Disappoint, source:SeekingAlpha, summary: The stock market is revealing a new positive message, even as market participants sell on earnings reports. Click here to read more about the market outlook., Headline: DexCom Inc. stock underperforms Monday when compared to competitors, source:MarketWatch, summary: No summary",DXCM
241,2023-07-24,"Headline: DexCom (DXCM) to Report Q2 Earnings: What's in the Cards?, source:Yahoo, summary: DexCom's (DXCM) second-quarter 2023 results are likely to reflect rising volumes across all channels., Headline: Are Medical Stocks Lagging  Boston Scientific (BSX) This Year?, source:Yahoo, summary: Here is how Boston Scientific (BSX) and DexCom (DXCM) have performed compared to their sector so far this year.",DXCM
242,2023-07-25,"Headline: Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick, source:Yahoo, summary: The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage., Headline: DexCom Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: Shares of DexCom Inc. advanced 1.75% to $129.96 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500..., Headline: EVP Managing Director Steven Pacelli Sells 412 Shares of DexCom Inc, source:Yahoo, summary: On July 24, 2023, Steven Pacelli, the Executive Vice President and Managing Director of DexCom Inc (NASDAQ:DXCM), sold 412 shares of the company.",DXCM
243,2023-07-26,"Headline: If You Invested $1000 In This Stock 15 Years Ago, You Would Have $75,000 Today, source:Benzinga, summary: No summary, Headline: DexCom Inc. stock underperforms Wednesday when compared to competitors despite daily gains, source:MarketWatch, summary: Shares of DexCom Inc. inched 0.56% higher to $130.69 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow..., Headline: GLOBAL BRIEFING: Stocks rise on hopes Fed's hiking cycle is over, source:Alliance News, summary: No summary, Headline: DexCom options imply 5.7% move in share price post-earnings, source:Thefly.com, summary: No summary, Headline: DexCom  reports Q2 EPS 28c, consensus 23c, source:Thefly.com, summary: No summary, Headline: DexCom  sees FY23 revenue $3.5B-$3.55B, consensus $3.5B, source:Thefly.com, summary: No summary, Headline: DexCom Non-GAAP EPS of $0.34 beats by $0.11, revenue of $871.3M beats by $30.35M, source:Seeking Alpha, summary: No summary",DXCM
244,2023-07-27,"Headline: DexCom boosts 2023 revenue guidance on Q2 results, source:Seeking Alpha, summary: No summary, Headline: Fly Intel: After-Hours Movers, source:Thefly.com, summary: No summary, Headline: Notable companies reporting after market close, source:Thefly.com, summary: No summary, Headline: DexCom: Q2 Earnings Snapshot, source:Associated Press, The, summary: No summary, Headline: DexCom : Q2 Earnings Snapshot, source:Finnhub, summary: SAN DIEGO  — SAN DIEGO  — DexCom Inc.  on Thursday reported second-quarter earnings of $115.9 million.
  The San Diego-based company said it had profit of 28 cents per share. Earnings,..., Headline: DexCom Inc. stock outperforms competitors despite losses on the day, source:MarketWatch, summary: Shares of DexCom Inc. shed 1.02% to $129.36 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index..., Headline: Dexcom lifts revenue forecast on demand for glucose-monitoring devices, source:Finnhub, summary: Medical device maker Dexcom Inc
on Thursday raised its annual revenue forecast after
strong demand for its continuous glucose monitoring 
systems boosted second-quarter results, lifting its shares..., Headline: Stocks making the biggest moves after hours: Intel, Ford, Roku, Enphase Energy and more, source:CNBC, summary: These are the stocks posting the largest moves in extended trading. , Headline: DexCom, Inc. 2023 Q2 - Results - Earnings Call Presentation, source:SeekingAlpha, summary: The following slide deck was published by DexCom, Inc., Headline: Dexcom Reports Second Quarter 2023 Financial Results, source:Yahoo, summary: SAN DIEGO, July 27, 2023--Dexcom Reports Second Quarter 2023 Financial Results, Headline: Dexcom, Inc. (DXCM) Q2 2023 Earnings Call Transcript, source:SeekingAlpha, summary: Dexcom, Inc. (NASDAQ:NASDAQ:DXCM) Q2 2023 Earnings Conference Call July 27, 2023 4:30 PM ETCompany ParticipantsSean Christensen - Director, Corporate Affairs & Head of IRKevin Sayer -..., Headline: Dexcom Earnings Tops Estimates, Medical Device Maker Hikes Outlook, source:Yahoo, summary: Dexcom reported June-quarter earnings and revenue that topped Wall Street targets and raised its full-year sales outlook., Headline: DexCom (DXCM) Beats Q2 Earnings and Revenue Estimates, source:Yahoo, summary: DexCom (DXCM) delivered earnings and revenue surprises of 54.55% and 4.10%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?, Headline: Compared to Estimates, DexCom (DXCM) Q2 Earnings: A Look at Key Metrics, source:Yahoo, summary: Although the revenue and EPS for DexCom (DXCM) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.",DXCM
245,2023-07-28,"Headline: DexCom (DXCM) Q2 2023 Earnings Call Transcript, source:Yahoo, summary: Image source: The Motley Fool.  DexCom (NASDAQ: DXCM)Q2 2023 Earnings CallJul 27, 2023, 4:30 p.m. ETContents:  Prepared Remarks Questions and Answers Call Participants  Prepared Remarks:  OperatorLadies and gentlemen, welcome to the DexCom second quarter 2023 earnings release conference call., Headline: DexCom price target raised to $153 from $145 at Baird, source:Thefly.com, summary: No summary, Headline: DexCom price target raised to $150 from $135 at Canaccord, source:Thefly.com, summary: No summary, Headline: Analysts Offer Insights on Healthcare Companies: Dexcom (DXCM), Evolus (EOLS) and Icon (ICLR), source:TipRanks, summary: No summary, Headline: DexCom price target raised to $150 from $135 at Oppenheimer, source:Thefly.com, summary: No summary, Headline: Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV), Axonics Modulation Technologies (AXNX) and Dexcom (DXCM), source:TipRanks, summary: No summary, Headline: 6 Analysts Have This to Say About DexCom, source:Benzinga, summary: No summary, Headline: DexCom price target raised to $160 from $150 at Piper Sandler, source:Thefly.com, summary: No summary, Headline: DexCom price target raised to $154 from $140 at Raymond James, source:Thefly.com, summary: No summary, Headline: Early notable gainers among liquid option names on July 28th, source:Thefly.com, summary: No summary, Headline: Skechers, Chart Industries, Roku, Beazer Homes And Other Big Stocks Moving Higher On Friday, source:Benzinga, summary: No summary, Headline: Is DexCom (DXCM) Stock Fairly Valued? An In-Depth Analysis, source:GuruFocus, summary: No summary, Headline: Q2 2023 Dexcom Inc Earnings Call, source:Yahoo, summary: Q2 2023 Dexcom Inc Earnings Call, Headline: DexCom (DXCM) Q2 Earnings Beat Estimates, Volumes Remain Strong, source:Yahoo, summary: DexCom's (DXCM) second-quarter 2023 results reflect strong domestic and international revenue growth on the back of its real-time Continuous Glucose Monitoring system., Headline: Dow Jones Rises, Market Rallies Back As Inflation Cools; 5 Earnings Winners, source:Yahoo, summary: The Dow Jones and other major indexes rebounded, with key inflation data cooling. Roku and Intel were big earnings winners., Headline: DexCom Inc. stock rises Friday, outperforms market, source:MarketWatch, summary: Shares of DexCom Inc. rose 2.33% to $132.38 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index...",DXCM
246,2023-07-29,"Headline: Piper Sandler Maintains Dexcom (DXCM) Overweight Recommendation, source:Fintel, summary: nan, Headline: Canaccord Genuity Maintains Dexcom (DXCM) Buy Recommendation, source:Fintel, summary: nan, Headline: Raymond James Maintains Dexcom (DXCM) Strong Buy Recommendation, source:Fintel, summary: nan, Headline: Baird Maintains Dexcom (DXCM) Outperform Recommendation, source:Fintel, summary: nan",DXCM
247,2023-07-30,"Headline: Baron Opportunity Fund Q2 2023 Shareholder Letter, source:SeekingAlpha, summary: During Q2 2023, Baron Opportunity FundÂ® climbed 16.31% (Institutional Shares), outperforming the broader market. Click here to read the full fund letter., Headline: Baron Small Cap Fund Q2 2023 Shareholder Letter, source:SeekingAlpha, summary: Baron Small Cap FundÂ® was up 6.49% (Institutional Shares) in the Q2 2023 and was up 16.54% for the first half of the year. Click here to read the full fund letter., Headline: Monday Sector Laggards: Healthcare, Utilities, source:Market News Video, summary: No summary, Headline: Why Apellis Pharmaceuticals  Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Monday's Session, source:Benzinga, summary: No summary",DXCM
248,2023-07-31,"Headline: DexCom price target raised to $138 from $115 at Barclays, source:Thefly.com, summary: No summary, Headline: Video: Nasdaq 100 Movers: DXCM, SIRI, source:Market News Video, summary: No summary, Headline: Barclays Maintains Dexcom (DXCM) Equal-Weight Recommendation, source:Fintel, summary: nan, Headline: Tracking Baillie Gifford's 13F Portfolio - Q2 2023 Update, source:SeekingAlpha, summary: Baillie Gifford's 13F portfolio value increased from ~$111B to ~$118B this quarter. Top three holdings make up ~17% of the portfolio. Click here to read more., Headline: DexCom Inc. stock underperforms Monday when compared to competitors, source:MarketWatch, summary: Shares of DexCom Inc. slipped 5.91% to $124.56 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index..., Headline: S&P 500: Entertainment Giants, AI Play Lead Monday's 5 Best; Medtech Firms Sicken, source:Yahoo, summary: Paramount and Disney, along with AI play Adobe, led the S&P 500. Dexcom and several medical products firms struggled., Headline: DexCom: I Expect Growth To Continue At This Strong Rate, Buy, source:SeekingAlpha, summary: DexCom posted strong results for 2Q23, with revenues of $871 million and EPS beating expectations. See why we believe DXCM stock is a buy., Headline: DexCom Inc. stock falls Tuesday, underperforms market, source:MarketWatch, summary: No summary",DXCM
249,2023-08-01,"Headline: DexCom Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: No summary",DXCM
250,2023-08-02,"Headline: DexCom Inc. stock falls Thursday, underperforms market, source:MarketWatch, summary: No summary",DXCM
251,2023-08-03,"Headline: DexCom put volume heavy and directionally bearish, source:Thefly.com, summary: No summary, Headline: DexCom Inc. stock falls Friday, underperforms market, source:MarketWatch, summary: No summary",DXCM
252,2023-08-04,"Headline: Stryker Corp (SYK): A High-Performing Medical Device Stock with a GF Score of 90, source:GuruFocus, summary: No summary",DXCM
253,2023-08-06,"Headline: DexCom Inc. stock rises Monday, still underperforms market, source:MarketWatch, summary: No summary",DXCM
254,2023-08-07,"Headline: DexCom Inc. stock falls Tuesday, underperforms market, source:MarketWatch, summary: No summary",DXCM
255,2023-08-08,"Headline: DXCM Makes Notable Cross Below Critical Moving Average, source:Market News Video, summary: No summary, Headline: Here's Why You Should Retain Insulet (PODD) Stock for Now, source:Yahoo, summary: Investors continue to be optimistic about Insulet (PODD) on the strength of the Omnipod 5 AID system., Headline: 10 Health Care Stocks With Whale Alerts In Today's Session, source:Benzinga, summary: No summary, Headline: Inogen (INGN) Q2 Earnings Beat Estimates, Revenues Down Y/Y, source:Yahoo, summary: Despite higher domestic business-to-business sales and rental revenues, Inogen's (INGN) overall second-quarter results reflect soft performances., Headline: Is DexCom Inc (DXCM) Modestly Undervalued? A Comprehensive Analysis, source:Yahoo, summary: An in-depth look at the valuation, financial strength, profitability, and growth of DexCom Inc (DXCM), Headline: DexCom Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: No summary",DXCM
256,2023-08-09,"Headline: This Is What Whales Are Betting On DexCom, source:Benzinga, summary: No summary, Headline: At US$110, Is DexCom, Inc. (NASDAQ:DXCM) Worth Looking At Closely?, source:Yahoo, summary: DexCom, Inc. ( NASDAQ:DXCM ) received a lot of attention from a substantial price movement on the NASDAQGS over the..., Headline: Investing $1,000 in These 2 Top Stocks Would Be a Brilliant Move, source:Yahoo, summary: For those needing inspiration, let's consider two stocks worth investing in: HCA Healthcare (NYSE: HCA) and DexCom (NASDAQ: DXCM).  HCA Healthcare runs a business that most people will have to interact with at some point.  The company is one of the largest hospital chains in the U.S. It ended the second quarter with 182 hospitals, unchanged from the previous year's comparable period., Headline: Masimo (MASI) Q2 Earnings Lag Estimates, Margins Rise, source:Yahoo, summary: Despite strength in Hearables category, Masimo's (MASI) overall second-quarter results reflect soft performances., Headline: DexCom Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: No summary",DXCM
257,2023-08-10,"Headline: Analysts Have Conflicting Sentiments on These Healthcare Companies: Charles River Labs (CRL), Vertex (VERX) and Dexcom (DXCM), source:TipRanks, summary: No summary, Headline: Early notable gainers among liquid option names on August 10th, source:Thefly.com, summary: No summary, Headline: $1000 Invested In DexCom 10 Years Ago Would Be Worth This Much Today, source:Benzinga, summary: No summary, Headline: What Are the Best Companies to Invest in Now? Our 3 Picks for August, source:Yahoo, summary: Uncertainty from geopolitical tensions within the Ukraine war and China issues has led to slower United States labor market growth. In this environment of uncertainty, the United States labor market has displayed a degree of resilience but at a notably slower pace of growth. On the other hand, this has led to the rise of the best companies to invest in. Recent data released by the Labor Department underscores this cautious trend, as it’s revealed that U.S. employers added 187,000 jobs in July, r, Headline: Avanos (AVNS) Q2 Earnings and Revenues Fall Shy of Estimates, source:Yahoo, summary: Despite strength in Avanos' (AVNS) Digestive Health segment, its overall second-quarter results reflect soft performances., Headline: Accuray (ARAY) Q4 Earnings and Revenues Lag Estimates, source:Yahoo, summary: Accuray (ARAY) reports a solid fiscal fourth quarter top line on the back of robust segmental performances., Headline: Is DexCom Inc (DXCM) Modestly Undervalued? A Comprehensive Valuation Analysis, source:Yahoo, summary: Insights into DexCom's financial performance, growth prospects, and intrinsic value, Headline: DexCom Inc. stock falls Friday, underperforms market, source:MarketWatch, summary: No summary",DXCM
258,2023-08-11,"Headline: How Is The Market Feeling About DexCom?, source:Benzinga, summary: No summary",DXCM
259,2023-08-13,"Headline: The Sell-Off Caused By Wegovy And Mounjaro In Medtech Stocks Offers A Huge Opportunity, source:SeekingAlpha, summary: Medical device stocks have experienced sell-offs due to concerns about the future impact of Wegovy And Mounjaro drugs. Read more to see my thoughts., Headline: DexCom Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: No summary",DXCM
260,2023-08-14,"Headline: Abbott (ABT) EPD Arm Grows, Low Testing Sales Play Spoilsport, source:Yahoo, summary: Banking on the successful execution of Abbott's (ABT) branded generic operating model, EPD is well positioned for sustained growth in many of the growing pharmaceutical markets., Headline: Is DexCom Inc (DXCM) Modestly Undervalued? A Comprehensive Valuation Analysis, source:Yahoo, summary: Understanding DexCom's intrinsic value and its potential for future returns, Headline: DexCom Inc. stock outperforms market despite losses on the day, source:MarketWatch, summary: No summary",DXCM
261,2023-08-15,"Headline: Dexcom Canada Achieves Great Place to Work® Certification for Second Consecutive Year, source:Yahoo, summary: BURNABY, British Columbia, August 15, 2023--Dexcom, Inc. (NASDAQ:DXCM), a global leader in real-time continuous glucose monitoring (rtCGM), is proud to announce that for the second consecutive year, it has been certified as a Great Place to Work® in Canada for 2023-24. Awarded by Great Place to Work Institute®, the global authority on workplace culture, this certification is based on direct feedback from employees about their workplace experience, and the sentiment of pride they feel in represen, Headline: Is Caribou Biosciences (CRBU) Stock Outpacing Its Medical Peers This Year?, source:Yahoo, summary: Here is how Caribou Biosciences, Inc. (CRBU) and DexCom (DXCM) have performed compared to their sector so far this year., Headline: DexCom Inc. stock underperforms Wednesday when compared to competitors, source:MarketWatch, summary: No summary",DXCM
262,2023-08-16,"Headline: Amazon Pharmacy will offer $35 insulin as price cuts continue throughout the industry, source:Yahoo, summary: Amazon Pharmacy announced Tuesday its latest move to improve price transparency for pharmacy customers., Headline: DexCom Inc. stock underperforms Thursday when compared to competitors, source:MarketWatch, summary: No summary",DXCM
263,2023-08-17,"Headline: Cohen’s Point72 Cuts Broadcom, Meta, Google to Push Into Microsoft, NVIDIA and Micron, source:Fintel, summary: nan",DXCM
264,2023-08-18,"Headline: DexCom Inc. stock underperforms Friday when compared to competitors, source:MarketWatch, summary: Shares of DexCom Inc. shed 1.63% to $106.05 Friday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...",DXCM
265,2023-08-20,"Headline: 7 Top Stock Opportunities on the Heels of the Latest Jobs Report, source:Yahoo, summary: The latest jobs report showed a slowing pace of hiring which will affect stock market opportunities. The July jobs report showed slowing hiring with low unemployment. The economy continues to cool, which lessens the chances that the Fed will decide to raise rates when the FOMC meets next in September. This signals investors that a soft landing remains a distinct possibility and that the markets can continue to move upward. Yet the economy continues to be challenging to judge, with many prominent, Headline: Where DexCom Stands With Analysts, source:Benzinga, summary: No summary, Headline: DexCom price target lowered to $130 from $153 at Baird, source:Thefly.com, summary: No summary",DXCM
266,2023-08-21,"Headline: 3 Best Stocks to Buy Now, 8/21/2023, According to Top Analysts, source:TipRanks, summary: No summary, Headline: DexCom Inc. stock underperforms Monday when compared to competitors, source:MarketWatch, summary: Shares of DexCom Inc. slipped 1.29% to $104.68 Monday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index..., Headline: Check Out What Whales Are Doing With DXCM, source:Benzinga, summary: No summary",DXCM
267,2023-08-22,"Headline: Baird Maintains Dexcom (DXCM) Outperform Recommendation, source:Fintel, summary: nan, Headline: 3 Revolutionary Stocks I'd Buy Right Now Without Hesitation, source:Yahoo, summary: Investors looking to earn outsized returns over long periods (which describes most investors) would do well to consider shares of innovative companies such as CRISPR Therapeutics (NASDAQ: CRSP), Sarepta Therapeutics (NASDAQ: SRPT), and DexCom (NASDAQ: DXCM).  Gene-editing specialist CRISPR Therapeutics currently has no products on the market., Headline: DexCom Inc. stock rises Tuesday, outperforms market, source:MarketWatch, summary: Shares of DexCom Inc. rallied 2.20% to $106.98 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index..., Headline: Is DexCom Inc (DXCM) Modestly Undervalued? A Comprehensive Valuation Analysis, source:Yahoo, summary: Unveiling the intrinsic value of DexCom's stock through the lens of GuruFocus' proprietary valuation method",DXCM
268,2023-08-23,"Headline: Elliott Wave Technical Analysis: DexCom Inc. - Wednesday, Aug. 23, source:TalkMarkets, summary: No summary, Headline: DexCom Inc. stock underperforms Wednesday when compared to competitors, source:MarketWatch, summary: Shares of DexCom Inc. shed 2.43% to $104.38 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...",DXCM
269,2023-08-24,"Headline: Estimating The Intrinsic Value Of DexCom, Inc. (NASDAQ:DXCM), source:Yahoo, summary: Key Insights The projected fair value for DexCom is US$100 based on 2 Stage Free Cash Flow to Equity With US$104 share..., Headline: EVP Managing Director Steven Pacelli Sells 411 Shares of DexCom Inc, source:GuruFocus, summary: No summary, Headline: DexCom put volume heavy and directionally bearish, source:Thefly.com, summary: No summary, Headline: DexCom Inc. stock falls Thursday, underperforms market, source:MarketWatch, summary: Shares of DexCom Inc. shed 3.26% to $100.98 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index...",DXCM
270,2023-08-25,"Headline: DexCom Inc. stock falls Friday, underperforms market, source:MarketWatch, summary: Shares of DexCom Inc. sank 0.22% to $100.76 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...",DXCM
271,2023-08-28,"Headline: Jefferies healthcare analyst holds an analyst/industry conference call, source:Thefly.com, summary: No summary, Headline: 1 Stock-Split Stock Billionaires Are Buying Hand Over Fist and 1 Unexpected Stock-Split Stock They're Selling, source:Yahoo, summary: From time to time, shares of successful companies rise so high that everyday investors begin to shun them for no other reason than their high share price.  Stock splits allow companies to lower their stock prices to levels within reach of everyday investors by turning one share into 10, for example.  In theory, multiplying the number of outstanding shares by a specific amount should lower the price by an equal magnitude In practice, though, the extra attention that surrounds stock splits tends to drive their prices higher., Headline: Dexcom Appoints Rimma Driscoll to Board of Directors, source:Yahoo, summary: SAN DIEGO, August 28, 2023--Dexcom Appoints Rimma Driscoll to Board of Directors, Headline: DexCom Inc. stock falls Monday, underperforms market, source:MarketWatch, summary: Shares of DexCom Inc. slipped 1.46% to $99.29 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...",DXCM
272,2023-08-29,"Headline: $1000 Invested In DexCom 15 Years Ago Would Be Worth This Much Today, source:Benzinga, summary: No summary, Headline: JPMorgan says time to buy MedTech based on past, source:Seeking Alpha, summary: No summary, Headline: Is DexCom (DXCM) Significantly Undervalued? A Comprehensive Analysis, source:Yahoo, summary: Unearthing the True Value of DexCom Inc (DXCM), Headline: DexCom Inc. stock rises Tuesday, still underperforms market, source:MarketWatch, summary: Shares of DexCom Inc. advanced 1.30% to $100.58 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...",DXCM
273,2023-08-30,"Headline: Early notable gainers among liquid option names on August 30th, source:Thefly.com, summary: No summary, Headline: Dexcom Announces Upcoming Conference Presentations, source:Yahoo, summary: SAN DIEGO, August 30, 2023--DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the following upcoming investor conferences:, Headline: Is Trending Stock DexCom, Inc. (DXCM) a Buy Now?, source:Yahoo, summary: No summary, Headline: DexCom Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: Shares of DexCom Inc. advanced 2.82% to $103.42 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500..., Headline: Stocks Keep Up Summer Rally Ahead of Inflation Data, source:Yahoo, summary: The S&P 500 increased 0.4%.  The tech-heavy Nasdaq Composite gained 0.5% while the blue-chip Dow Jones Industrial Average rose 38 points, or 0.1%.  U.S. gross domestic product rose at a 2.1% annualized rate in April through June after adjusting for seasonal effects and inflation, the Commerce Department said Wednesday.",DXCM
274,2023-08-31,"Headline: Should You Hold DexCom (DXCM)?, source:Yahoo, summary: Baron Funds, an investment management company, released its “Baron Small Cap Fund” second-quarter 2023 investor letter. A copy of the same can be downloaded here. The fund was 6.49% (Institutional Shares) up in the second quarter and 16.54% up for the first half of the year. This quarter, the Fund underperformed the broader S&P 500 Index, […], Headline: DexCom Inc. stock falls Thursday, underperforms market, source:MarketWatch, summary: Shares of DexCom Inc. slid 2.36% to $100.98 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index...",DXCM
275,2023-09-01,"Headline: Dexcom G6 Strengthens Its Position as World's Most Connected CGM System With a New Aid Offering in Germany, source:Finnhub, summary: The world’s most connected continuous glucose monitoring system,† Dexcom G6, is now the first and only CGM to connect with the Omnipod 5 Automated Insulin Delivery System in Germany...., Headline: Dexcom G6 strengthens position as world’s most connected CGM system with a new aid offering in Germany, source:Seeking Alpha, summary: No summary, Headline: Dexcom G6 Strengthens Its Position as World’s Most Connected CGM System With a New Aid Offering in Germany, source:Yahoo, summary: MAINZ, Germany, September 01, 2023--The Dexcom G6 is now the first and only CGM to connect with the Omnipod 5 Automated Insulin Delivery (AID) System in Germany., Headline: DexCom Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: Shares of DexCom Inc. inched 0.91% higher to $101.90 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P..., Headline: DexCom (DXCM) Outpaces Stock Market Gains: What You Should Know, source:Yahoo, summary: In the latest trading session, DexCom (DXCM) closed at $101.90, marking a +0.91% move from the previous day.",DXCM
